The neurobiology and treatment of first-episode schizophrenia

It is evident that once psychosis is present in patients with schizophrenia, the underlying biological process of the illness has already been ongoing for many years. At the time of diagnosis, patients with schizophrenia show decreased mean intracranial volume (ICV) as compared with healthy subjects...

Full description

Saved in:
Bibliographic Details
Published inMolecular psychiatry Vol. 20; no. 1; pp. 84 - 97
Main Authors Kahn, R S, Sommer, I E
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.02.2015
Nature Publishing Group
Subjects
631/378/2649
631/378/340
692/699/476/1799
692/700/565
Age of Onset
Anniversaries
Antipsychotic Agents - therapeutic use
Antipsychotics
Behavioral Sciences
Biological Psychology
Brain - pathology
Care and treatment
Cognition Disorders - etiology
Dopamine
Expert Review
Humans
Longitudinal studies
Medical imaging
Medicine
Medicine & Public Health
Neurobiology
Neuroimaging
Neurophysiology
Neurosciences
Pharmacotherapy
Physiological aspects
Psychiatric research
Psychiatry
Psychosis
Psychotropic drugs
Receptors, N-Methyl-D-Aspartate - metabolism
Schizophrenia
Schizophrenia - complications
Schizophrenia - genetics
Schizophrenia - pathology
Schizophrenia - therapy
Netherlands
Online AccessGet full text

Cover

Abstract It is evident that once psychosis is present in patients with schizophrenia, the underlying biological process of the illness has already been ongoing for many years. At the time of diagnosis, patients with schizophrenia show decreased mean intracranial volume (ICV) as compared with healthy subjects. Since ICV is driven by brain growth, which reaches its maximum size at approximately 13 years of age, this finding suggests that brain development in patients with schizophrenia is stunted before that age. The smaller brain volume is expressed as decrements in both grey and white matter. After diagnosis, it is mainly the grey matter loss that progresses over time whereas white matter deficits are stable or may even improve over the course of the illness. To understand the possible causes of the brain changes in the first phase of schizophrenia, evidence from treatment studies, postmortem and neuroimaging investigations together with animal experiments needs to be incorporated. These data suggest that the pathophysiology of schizophrenia is multifactorial. Increased striatal dopamine synthesis is already evident before the time of diagnosis, starting during the at-risk mental state, and increases during the onset of frank psychosis. Cognitive impairment and negative symptoms may, in turn, result from other abnormalities, such as NMDA receptor hypofunction and low-grade inflammation of the brain. The latter two dysfunctions probably antedate increased dopamine synthesis by many years, reflecting the much earlier presence of cognitive and social dysfunction. Although correction of the hyperdopaminergic state with antipsychotic agents is generally effective in patients with a first-episode psychosis, the effects of treatments to correct NMDA receptor hypofunction or low-grade inflammation are (so far) rather modest at best. Improved efficacy of these interventions can be expected when they are applied at the onset of cognitive and social dysfunction, rather than at the onset of psychosis.
AbstractList It is evident that once psychosis is present in patients with schizophrenia, the underlying biological process of the illness has already been ongoing for many years. At the time of diagnosis, patients with schizophrenia show decreased mean intracranial volume (ICV) as compared with healthy subjects. Since ICV is driven by brain growth, which reaches its maximum size at approximately 13 years of age, this finding suggests that brain development in patients with schizophrenia is stunted before that age. The smaller brain volume is expressed as decrements in both grey and white matter. After diagnosis, it is mainly the grey matter loss that progresses over time whereas white matter deficits are stable or may even improve over the course of the illness. To understand the possible causes of the brain changes in the first phase of schizophrenia, evidence from treatment studies, postmortem and neuroimaging investigations together with animal experiments needs to be incorporated. These data suggest that the pathophysiology of schizophrenia is multifactorial. Increased striatal dopamine synthesis is already evident before the time of diagnosis, starting during the at-risk mental state, and increases during the onset of frank psychosis. Cognitive impairment and negative symptoms may, in turn, result from other abnormalities, such as NMDA receptor hypofunction and low-grade inflammation of the brain. The latter two dysfunctions probably antedate increased dopamine synthesis by many years, reflecting the much earlier presence of cognitive and social dysfunction. Although correction of the hyperdopaminergic state with antipsychotic agents is generally effective in patients with a first-episode psychosis, the effects of treatments to correct NMDA receptor hypofunction or low-grade inflammation are (so far) rather modest at best. Improved efficacy of these interventions can be expected when they are applied at the onset of cognitive and social dysfunction, rather than at the onset of psychosis.
It is evident that once psychosis is present in patients with schizophrenia, the underlying biological process of the illness has already been ongoing for many years. At the time of diagnosis, patients with schizophrenia show decreased mean intracranial volume (ICV) as compared with healthy subjects. Since ICV is driven by brain growth, which reaches its maximum size at approximately 13 years of age, this finding suggests that brain development in patients with schizophrenia is stunted before that age. The smaller brain volume is expressed as decrements in both grey and white matter. After diagnosis, it is mainly the grey matter loss that progresses over time whereas white matter deficits are stable or may even improve over the course of the illness. To understand the possible causes of the brain changes in the first phase of schizophrenia, evidence from treatment studies, postmortem and neuroimaging investigations together with animal experiments needs to be incorporated. These data suggest that the pathophysiology of schizophrenia is multifactorial. Increased striatal dopamine synthesis is already evident before the time of diagnosis, starting during the at-risk mental state, and increases during the onset of frank psychosis. Cognitive impairment and negative symptoms may, in turn, result from other abnormalities, such as NMDA receptor hypofunction and low-grade inflammation of the brain. The latter two dysfunctions probably antedate increased dopamine synthesis by many years, reflecting the much earlier presence of cognitive and social dysfunction. Although correction of the hyperdopaminergic state with antipsychotic agents is generally effective in patients with a first-episode psychosis, the effects of treatments to correct NMDA receptor hypofunction or low-grade inflammation are (so far) rather modest at best. Improved efficacy of these interventions can be expected when they are applied at the onset of cognitive and social dysfunction, rather than at the onset of psychosis.It is evident that once psychosis is present in patients with schizophrenia, the underlying biological process of the illness has already been ongoing for many years. At the time of diagnosis, patients with schizophrenia show decreased mean intracranial volume (ICV) as compared with healthy subjects. Since ICV is driven by brain growth, which reaches its maximum size at approximately 13 years of age, this finding suggests that brain development in patients with schizophrenia is stunted before that age. The smaller brain volume is expressed as decrements in both grey and white matter. After diagnosis, it is mainly the grey matter loss that progresses over time whereas white matter deficits are stable or may even improve over the course of the illness. To understand the possible causes of the brain changes in the first phase of schizophrenia, evidence from treatment studies, postmortem and neuroimaging investigations together with animal experiments needs to be incorporated. These data suggest that the pathophysiology of schizophrenia is multifactorial. Increased striatal dopamine synthesis is already evident before the time of diagnosis, starting during the at-risk mental state, and increases during the onset of frank psychosis. Cognitive impairment and negative symptoms may, in turn, result from other abnormalities, such as NMDA receptor hypofunction and low-grade inflammation of the brain. The latter two dysfunctions probably antedate increased dopamine synthesis by many years, reflecting the much earlier presence of cognitive and social dysfunction. Although correction of the hyperdopaminergic state with antipsychotic agents is generally effective in patients with a first-episode psychosis, the effects of treatments to correct NMDA receptor hypofunction or low-grade inflammation are (so far) rather modest at best. Improved efficacy of these interventions can be expected when they are applied at the onset of cognitive and social dysfunction, rather than at the onset of psychosis.
It is evident that once psychosis is present in patients with schizophrenia, the underlying biological process of the illness has already been ongoing for many years. At the time of diagnosis, patients with schizophrenia show decreased mean intracranial volume (ICV) as compared with healthy subjects. Since ICV is driven by brain growth, which reaches its maximum size at approximately 13 years of age, this finding suggests that brain development in patients with schizophrenia is stunted before that age. The smaller brain volume is expressed as decrements in both grey and white matter. After diagnosis, it is mainly the grey matter loss that progresses over time whereas white matter deficits are stable or may even improve over the course of the illness. To understand the possible causes of the brain changes in the first phase of schizophrenia, evidence from treatment studies, postmortem and neuroimaging investigations together with animal experiments needs to be incorporated. These data suggest that the pathophysiology of schizophrenia is multifactorial. Increased striatal dopamine synthesis is already evident before the time of diagnosis, starting during the at-risk mental state, and increases during the onset of frank psychosis. Cognitive impairment and negative symptoms may, in turn, result from other abnormalities, such as NMDA receptor hypofunction and low-grade inflammation of the brain. The latter two dysfunctions probably antedate increased dopamine synthesis by many years, reflecting the much earlier presence of cognitive and social dysfunction. Although correction of the hyperdopaminergic state with antipsychotic agents is generally effective in patients with a first-episode psychosis, the effects of treatments to correct NMDA receptor hypofunction or low-grade inflammation are (so far) rather modest at best. Improved efficacy of these interventions can be expected when they are applied at the onset of cognitive and social dysfunction, rather than at the onset of psychosis. Molecular Psychiatry (2015) 20, 84-97; doi: 10.1038/mp.2014.66; published online 22 July 2014
Audience Academic
Author Kahn, R S
Sommer, I E
Author_xml – sequence: 1
  givenname: R S
  surname: Kahn
  fullname: Kahn, R S
  email: r.kahn@umcutrecht.nl
  organization: Department of Psychiatry, Brain Center Rudolf Magnus, University Medical Centre Utrecht, Utrecht, The Netherlands
– sequence: 2
  givenname: I E
  surname: Sommer
  fullname: Sommer, I E
  organization: Department of Psychiatry, Brain Center Rudolf Magnus, University Medical Centre Utrecht, Utrecht, The Netherlands
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25048005$$D View this record in MEDLINE/PubMed
BookMark eNptkl1rFTEQhoNUbHv0xh8gC96Issd87-6FQil-QcGbeh2yyeSclN1kTXaF-uvNcmpta0kgIfPMm3kzOUVHIQZA6CXBW4JZ-36cthQTvpXyCTohvJG1EE17VPZMdDUnLT9GpzlfYbwGxTN0TAXmLcbiBH243EMVYEmx93GIu-tKB1vNCfQ8Qpir6CrnU55rmHyOFqps9v53nPYJgtfP0VOnhwwvbtYN-vH50-X51_ri-5dv52cXtZFczHVnCbW6E7wDSrQWGjPLjTUU9wRzRznWDCxnvXEGa1kK7hnthRCSaNM4zjbo40F3WvoRrCmVJT2oKflRp2sVtVf3I8Hv1S7-UpxRTNu2CLy5EUjx5wJ5VqPPBoZBB4hLVkQKylnXSFLQ1w_Qq7ikUOytFO6apmvaf9ROD6B8cLHca1ZRdcYxoUSwMjdo-whVhoXRm9JF58v5vYRXd43eOvzbsAK8PQAmxZwTuFuEYLX-BjVOav0NSsoC4wew8bOefVwfyQ-Pp7w7pOSiG3aQ7rj_n_4DTxnD5w
CitedBy_id crossref_primary_10_1038_s41537_021_00196_7
crossref_primary_10_1016_j_bbr_2016_03_051
crossref_primary_10_1016_j_pnpbp_2019_109825
crossref_primary_10_1007_s12031_017_0920_2
crossref_primary_10_1093_schbul_sbae026
crossref_primary_10_3389_fnins_2021_641047
crossref_primary_10_1007_s12031_020_01670_0
crossref_primary_10_1186_s13063_019_3786_5
crossref_primary_10_1016_j_nicl_2019_101725
crossref_primary_10_1016_j_ebiom_2019_07_026
crossref_primary_10_1038_s41467_024_50267_3
crossref_primary_10_1038_s41537_022_00308_x
crossref_primary_10_1111_acps_12955
crossref_primary_10_1089_cap_2015_0220
crossref_primary_10_1017_S0033291716002476
crossref_primary_10_3389_fpsyt_2019_00275
crossref_primary_10_3390_biomedicines12102270
crossref_primary_10_1186_s12888_016_0769_x
crossref_primary_10_3390_ijms231810624
crossref_primary_10_1080_15622975_2020_1731925
crossref_primary_10_1016_j_rcpeng_2022_08_009
crossref_primary_10_1038_npjschz_2016_3
crossref_primary_10_1097_MD_0000000000007228
crossref_primary_10_26416_Psih_54_3_2018_1915
crossref_primary_10_1080_15622975_2019_1583371
crossref_primary_10_1007_s12264_016_0079_9
crossref_primary_10_1111_appy_12215
crossref_primary_10_1017_S0033291720000343
crossref_primary_10_1038_s41398_020_0828_4
crossref_primary_10_7759_cureus_23959
crossref_primary_10_1093_schbul_sbad047
crossref_primary_10_1038_s41598_021_98769_0
crossref_primary_10_1007_s11172_015_1144_7
crossref_primary_10_1017_neu_2020_12
crossref_primary_10_1016_j_euroneuro_2015_04_014
crossref_primary_10_1186_s12888_024_05897_8
crossref_primary_10_1093_schbul_sby125
crossref_primary_10_3109_08039488_2015_1112831
crossref_primary_10_1093_schbul_sbx031
crossref_primary_10_1016_j_schres_2021_02_017
crossref_primary_10_1080_07399332_2020_1781126
crossref_primary_10_3390_ph16111557
crossref_primary_10_1016_j_schres_2018_06_039
crossref_primary_10_1016_j_brainres_2017_08_022
crossref_primary_10_1016_j_jpsychires_2015_07_003
crossref_primary_10_1016_j_cyto_2017_04_004
crossref_primary_10_1176_appi_ajp_2015_15060753
crossref_primary_10_1038_s41398_022_02233_0
crossref_primary_10_1039_C7MD00448F
crossref_primary_10_3389_fnins_2016_00488
crossref_primary_10_1017_S0033291723000806
crossref_primary_10_1002_cne_24813
crossref_primary_10_1111_hex_13139
crossref_primary_10_1007_s40263_020_00765_x
crossref_primary_10_1038_tp_2015_156
crossref_primary_10_1016_j_ajp_2021_102688
crossref_primary_10_1134_S1607672916030029
crossref_primary_10_3390_life13102023
crossref_primary_10_1016_j_schres_2016_01_051
crossref_primary_10_1093_schizbullopen_sgaa005
crossref_primary_10_1016_j_mcna_2022_05_005
crossref_primary_10_3390_brainsci7040034
crossref_primary_10_1016_j_ajp_2023_103616
crossref_primary_10_3390_biomedicines11030895
crossref_primary_10_1111_pcn_12322
crossref_primary_10_1016_j_rcp_2025_01_001
crossref_primary_10_1002_ajmg_b_32519
crossref_primary_10_1021_cn5003368
crossref_primary_10_1186_s12991_025_00550_4
crossref_primary_10_1002_ddr_21337
crossref_primary_10_1016_j_nicl_2020_102239
crossref_primary_10_1016_j_bbr_2019_111946
crossref_primary_10_1097_YCO_0000000000000791
crossref_primary_10_1016_j_schres_2015_10_037
crossref_primary_10_1016_j_pbb_2021_173292
crossref_primary_10_1134_S102279542001010X
crossref_primary_10_2217_epi_2019_0350
crossref_primary_10_3390_ph14060514
crossref_primary_10_1016_j_cpnec_2023_100192
crossref_primary_10_1016_j_phrs_2022_106589
crossref_primary_10_1192_bjb_2019_90
crossref_primary_10_1016_j_bbi_2020_10_026
crossref_primary_10_1016_j_neubiorev_2017_12_008
crossref_primary_10_3390_brainsci13060848
crossref_primary_10_1016_j_pscychresns_2018_03_010
crossref_primary_10_1016_j_rpsmen_2020_09_002
crossref_primary_10_1016_j_schres_2015_03_003
crossref_primary_10_1016_j_inan_2024_100454
crossref_primary_10_1002_med_21512
crossref_primary_10_1038_s41380_022_01911_1
crossref_primary_10_1016_j_neuroscience_2016_02_043
crossref_primary_10_1016_j_schres_2017_08_063
crossref_primary_10_1016_j_brainres_2022_148153
crossref_primary_10_1136_bmjopen_2018_028029
crossref_primary_10_1038_s41598_018_29141_y
crossref_primary_10_3390_ijms21176106
crossref_primary_10_1016_j_neulet_2022_136918
crossref_primary_10_1016_j_pscychresns_2017_03_007
crossref_primary_10_1080_08039488_2017_1340518
crossref_primary_10_1080_15622975_2021_2022757
crossref_primary_10_3389_fnins_2019_00355
crossref_primary_10_1016_j_rcp_2020_11_005
crossref_primary_10_4155_bio_2018_0155
crossref_primary_10_1016_j_psiq_2020_10_004
crossref_primary_10_3390_antiox12051068
crossref_primary_10_1016_j_neulet_2017_04_025
crossref_primary_10_1038_mp_2015_141
crossref_primary_10_1038_s41398_019_0392_y
crossref_primary_10_1136_bmjment_2024_301184
crossref_primary_10_1016_j_expneurol_2015_08_019
crossref_primary_10_1016_j_neubiorev_2018_07_001
crossref_primary_10_1007_s40263_016_0343_6
crossref_primary_10_3389_fpsyt_2019_00885
crossref_primary_10_1017_S003329171500210X
crossref_primary_10_1155_2016_3915703
crossref_primary_10_1038_s41386_021_01016_3
crossref_primary_10_3389_fpsyt_2019_00363
crossref_primary_10_1016_j_drugalcdep_2020_107919
crossref_primary_10_3389_fpsyt_2021_613764
crossref_primary_10_1017_neu_2018_25
crossref_primary_10_1093_brain_awae321
crossref_primary_10_1016_j_jpsychires_2024_02_002
crossref_primary_10_1038_s41537_017_0035_3
crossref_primary_10_1007_s12264_021_00740_6
crossref_primary_10_3389_fpsyt_2019_00605
crossref_primary_10_1001_jamanetworkopen_2021_8810
crossref_primary_10_1016_j_schres_2015_05_034
crossref_primary_10_1177_0004867417699473
crossref_primary_10_1093_ijnp_pyx015
crossref_primary_10_1016_j_rpsm_2020_05_006
crossref_primary_10_7554_eLife_76391
crossref_primary_10_1007_s11682_020_00368_6
crossref_primary_10_1093_schbul_sbac069
crossref_primary_10_1016_j_pnpbp_2022_110697
crossref_primary_10_3389_fpsyt_2024_1358578
crossref_primary_10_1007_s40265_017_0789_y
crossref_primary_10_1016_j_psychres_2022_114850
crossref_primary_10_1017_S0033291723001381
crossref_primary_10_1093_nar_gkx1295
crossref_primary_10_1017_S0033291716002932
crossref_primary_10_34883_PI_2020_11_3_006
crossref_primary_10_1186_s12888_017_1383_2
crossref_primary_10_3389_fpsyt_2023_1231750
crossref_primary_10_1007_s12035_023_03694_0
crossref_primary_10_1016_j_schres_2023_10_008
crossref_primary_10_20473_jps_v8i1_14740
crossref_primary_10_1016_j_ijpsycho_2019_05_009
crossref_primary_10_3390_cimb46120812
crossref_primary_10_1016_j_jpsychires_2019_10_018
crossref_primary_10_1016_j_neubiorev_2018_09_027
crossref_primary_10_1186_s12993_019_0154_2
crossref_primary_10_25118_2763_9037_2019_v9_64
crossref_primary_10_1016_j_schres_2018_03_034
crossref_primary_10_1016_j_jsxm_2020_12_007
crossref_primary_10_1111_jnc_15243
crossref_primary_10_1186_s12916_024_03714_3
crossref_primary_10_1051_e3sconf_202455601004
crossref_primary_10_1016_j_euroneuro_2023_04_015
crossref_primary_10_3389_fpsyt_2021_653642
crossref_primary_10_7554_eLife_37799
crossref_primary_10_1016_j_pnpbp_2017_03_006
crossref_primary_10_18553_jmcp_2024_30_2_183
crossref_primary_10_1038_tp_2015_129
Cites_doi 10.1016/j.brainres.2008.08.023
10.3109/08039488.2012.745601
10.1176/appi.ajp.159.5.761
10.1016/j.schres.2009.08.012
10.1002/ana.22620
10.1192/bjp.188.6.510
10.1093/schbul/sbr017
10.1111/bjc.12027
10.1002/syn.20073
10.1016/j.biopsych.2009.03.013
10.1001/archpsyc.62.4.371
10.1016/0006-3223(88)90154-0
10.1097/JCP.0b013e318218dcd5
10.1038/sj.npp.1301624
10.1016/j.bbi.2014.01.003
10.1111/ijcp.12269
10.1038/nm1418
10.1016/j.biopsych.2013.09.018
10.1016/j.biopsych.2013.10.003
10.1016/j.schres.2007.05.008
10.1016/S0165-1781(00)00104-9
10.1016/j.tips.2013.01.001
10.1016/j.jpsychires.2007.10.001
10.1016/j.schres.2005.05.010
10.1016/j.schres.2013.05.024
10.1038/mp.2009.108
10.1038/mp.2009.121
10.1177/0269881105056530
10.1111/j.1440-1819.2009.01945.x
10.1007/BF03033242
10.1016/j.schres.2012.09.004
10.1038/nm1632
10.1016/j.biopsych.2010.11.030
10.1017/S1461145712000314
10.1007/s00401-008-0430-y
10.1016/j.schres.2009.03.036
10.1523/JNEUROSCI.2178-07.2007
10.1016/0006-3223(87)90104-1
10.1176/appi.ajp.2011.11010160
10.1038/sj.mp.4001558
10.1016/j.schres.2004.08.021
10.1001/2013.jamapsychiatry.86
10.1016/S0006-3223(99)00007-4
10.1038/nn2071
10.3171/jns.1999.91.4.0617
10.2967/jnumed.108.058669
10.1016/j.psychres.2013.03.004
10.1017/S1092852900027681
10.1016/j.psychsport.2013.04.005
10.1176/appi.ajp.161.6.1016
10.1093/jnen/59.2.137
10.1016/j.schres.2006.02.005
10.1111/j.1471-4159.2006.03964.x
10.2174/138955711795906941
10.5665/sleep.2712
10.1093/oxfordjournals.schbul.a006949
10.1093/brain/awt310
10.1016/j.biopsych.2010.08.024
10.1016/j.neubiorev.2012.09.006
10.1093/schbul/sbp006
10.1001/archpsyc.59.7.663
10.1016/j.schres.2013.05.027
10.2174/138161212799316244
10.1016/j.schres.2008.11.006
10.4088/JCP.09m05785yel
10.1038/nature08186
10.3109/15622975.2013.830774
10.1016/j.biopsych.2009.05.006
10.1152/jn.1988.60.2.645
10.1001/jamapsychiatry.2013.210
10.2174/138161212799958594
10.1192/bjp.126.5.414
10.1523/JNEUROSCI.21-13-04915.2001
10.1093/schbul/22.4.597
10.1159/000327682
10.1007/s00221-006-0472-0
10.1038/npp.2011.65
10.1016/j.bbi.2012.08.005
10.1080/15622970701227811
10.1016/S0140-6736(08)60486-9
10.1176/appi.ajp.159.11.1944
10.1016/j.schres.2007.01.019
10.1016/S0006-3223(03)00237-3
10.1016/j.schres.2009.11.011
10.1016/j.euroneuro.2011.03.004
10.1016/S0920-9964(00)00023-2
10.1093/schbul/sbp074
10.1176/appi.ajp.2013.12050674
10.1016/j.euroneuro.2012.04.015
10.1016/j.schres.2009.04.026
10.1176/appi.ajp.2011.11010052
10.1001/archgenpsychiatry.2010.199
10.1016/j.biopsych.2011.04.013
10.1177/070674371305800104
10.1016/j.schres.2007.11.028
10.1016/j.schres.2011.03.012
10.1016/S0006-3223(99)00109-2
10.1016/S0304-3940(99)00545-5
10.1016/0022-3956(82)90038-3
10.1093/schbul/sbr069
10.1017/S1461145710000313
10.1016/j.neuroimage.2005.07.038
10.1017/S0033291713000238
10.1016/S0920-9964(03)00129-4
10.1016/j.biopsych.2007.04.038
10.1111/j.1471-4159.2008.05675.x
10.1016/j.neuroimage.2011.11.080
10.1016/j.schres.2011.06.014
10.1016/j.clinph.2013.01.014
10.1523/JNEUROSCI.4457-08.2008
10.1016/j.schres.2013.02.017
10.1016/j.schres.2010.03.043
10.1038/sj.npp.1301444
10.1176/appi.ajp.2011.11030516
10.1016/j.neuron.2012.12.032
10.1038/mp.2012.110
10.1093/schbul/sbt139
10.1093/schbul/sbr133
10.1016/j.bbr.2008.12.022
10.1523/JNEUROSCI.1234-11.2011
10.1016/S0006-3223(03)00728-5
10.1176/ajp.156.10.1659
10.1093/schbul/sbs136
10.1111/j.1552-6569.2012.00779.x
10.1016/j.brainres.2006.10.011
10.1176/appi.ajp.161.8.1496
10.1016/j.neuron.2009.09.044
10.1016/S0006-8993(00)02984-X
10.1016/j.tins.2013.11.003
10.1073/pnas.0807746105
10.1371/journal.pone.0029341
10.1007/s00401-006-0090-8
10.1016/j.biopsych.2012.11.017
10.1176/appi.ajp.162.2.394
10.1001/archgenpsychiatry.2011.42
10.1176/appi.ajp.161.6.1116
10.1016/j.biopsych.2006.01.010
10.1016/j.eurpsy.2007.10.013
10.1016/S0920-9964(98)00113-3
10.1016/0006-3223(88)90144-8
10.1016/j.schres.2012.10.041
10.1152/ajpregu.00268.2005
10.1017/S1461145703003699
10.1017/S0033291700017608
10.1016/j.biopsych.2007.09.024
10.1038/nrn1648
10.1523/JNEUROSCI.22-09-03708.2002
10.2165/11586650-000000000-00000
10.1002/hbm.22075
10.1093/schbul/sbs092
10.1192/bjp.bp.105.015701
10.1001/jamapsychiatry.2013.155
10.1001/archpsyc.55.3.225
10.1016/j.jpsychires.2006.10.013
10.1007/BF01294737
10.1016/S0920-9964(03)00006-9
10.1176/appi.ajp.157.2.269
10.1016/j.schres.2007.11.010
10.1016/j.jpsychires.2006.07.002
10.1001/archpsyc.1982.04290100011003
10.1016/j.biopsych.2006.05.037
10.1523/JNEUROSCI.2904-12.2012
10.1016/0165-1781(83)90013-6
10.1095/biolreprod.104.027946
10.1038/mp.2012.199
10.3389/fncel.2013.00031
10.1523/JNEUROSCI.6158-09.2010
10.2478/s13380-012-0045-6
10.1016/j.neubiorev.2012.07.012
10.1517/13543784.2010.513382
10.1038/ejhg.2012.38
10.1001/jamapsychiatry.2013.3939
10.1038/tp.2012.116
10.1038/nature12929
10.1016/j.biopsych.2008.04.025
10.1093/schbul/sbs118
10.1016/B978-0-12-411512-5.00010-5
10.1038/nature09552
10.1038/mp.2011.20
10.1001/archpsyc.1997.01830220085012
10.1073/pnas.1208494109
10.1001/archgenpsychiatry.2008.514
10.1001/archgenpsychiatry.2011.88
10.1093/schbul/sbm168
10.1016/j.euroneuro.2012.08.008
10.1016/j.pscychresns.2008.11.001
10.1016/j.neubiorev.2013.11.006
10.1038/npp.2008.199
10.2967/jnumed.109.066647
10.1126/science.290.5499.2155
10.1001/archgenpsychiatry.2010.77
10.1016/j.schres.2013.06.040
10.1007/s00213-005-2250-2
10.1016/j.pscychresns.2006.05.009
10.1177/0269881111409265
10.1007/s00406-013-0399-y
10.1192/bjp.bp.106.033670
10.1016/j.schres.2007.03.022
10.1503/jpn.110181
10.1001/jamapsychiatry.2013.289
10.1111/acps.12029
10.1016/S0140-6736(95)91801-9
10.1157/13088411
10.1001/archgenpsychiatry.2011.46
10.1176/appi.ajp.2012.12010144
10.1016/j.schres.2006.03.042
10.1016/0006-3223(86)90285-4
10.1177/0269881111408964
10.9758/cpn.2012.10.1.13
10.1016/j.schres.2008.03.012
10.1007/s00406-011-0269-4
10.1001/archgenpsychiatry.2009.192
10.1001/archgenpsychiatry.2009.43
10.1016/j.biopsych.2010.08.033
10.1001/archgenpsychiatry.2009.193
10.1007/s00406-005-0618-2
10.1093/schbul/sbt124
10.1007/s00213-006-0570-5
ContentType Journal Article
Copyright The Author(s) 2015
COPYRIGHT 2015 Nature Publishing Group
Copyright Nature Publishing Group Feb 2015
Copyright © 2015 Macmillan Publishers Limited 2015 Macmillan Publishers Limited
Copyright_xml – notice: The Author(s) 2015
– notice: COPYRIGHT 2015 Nature Publishing Group
– notice: Copyright Nature Publishing Group Feb 2015
– notice: Copyright © 2015 Macmillan Publishers Limited 2015 Macmillan Publishers Limited
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TK
7X7
7XB
88E
88G
8AO
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2M
M7P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
5PM
DOI 10.1038/mp.2014.66
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Natural Science Journals
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Collection (ProQuest)
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Psychology Database (ProQuest)
Biological Science Database (ProQuest)
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Psychology
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList ProQuest One Psychology

MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
DocumentTitleAlternate Schizophrenia and onset of psychosis
EISSN 1476-5578
EndPage 97
ExternalDocumentID PMC4320288
3578564111
A401215315
25048005
10_1038_mp_2014_66
Genre Journal Article
Review
GeographicLocations Netherlands
GeographicLocations_xml – name: Netherlands
GroupedDBID ---
-Q-
0R~
123
29M
2WC
36B
39C
3V.
4.4
406
53G
70F
7X7
88E
8AO
8FI
8FJ
8R4
8R5
AACDK
AANZL
AASML
AATNV
AAYZH
AAZLF
ABAKF
ABAWZ
ABDBF
ABIVO
ABJNI
ABLJU
ABUWG
ABZZP
ACAOD
ACGFS
ACKTT
ACPRK
ACRQY
ACUHS
ACZOJ
ADBBV
ADHDB
AEFQL
AEJRE
AEMSY
AENEX
AEVLU
AEXYK
AFBBN
AFKRA
AFRAH
AFSHS
AGAYW
AGHAI
AGQEE
AHMBA
AHSBF
AIGIU
AILAN
AJRNO
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMYLF
AXYYD
AZQEC
B0M
BAWUL
BBNVY
BENPR
BHPHI
BKKNO
BPHCQ
BVXVI
C6C
CAG
CCPQU
COF
CS3
DIK
DNIVK
DPUIP
DU5
DWQXO
E3Z
EAD
EAP
EBC
EBD
EBLON
EBS
EE.
EIOEI
EJD
EMB
EMK
EMOBN
EPL
EPS
ESX
F5P
FDQFY
FEDTE
FERAY
FIGPU
FIZPM
FSGXE
FYUFA
GNUQQ
HCIFZ
HMCUK
HVGLF
HZ~
IAO
IHR
INH
INR
IPY
ITC
IWAJR
JSO
JZLTJ
KQ8
M1P
M2M
M7P
NAO
NQJWS
O9-
OK1
OVD
P2P
PQQKQ
PROAC
PSQYO
PSYQQ
Q2X
RNS
RNT
RNTTT
ROL
SNX
SNYQT
SOHCF
SOJ
SRMVM
SV3
SWTZT
TAOOD
TBHMF
TDRGL
TEORI
TR2
TSG
TUS
UKHRP
~8M
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
AEZWR
AFDZB
AFHIU
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
ABRTQ
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PQGLB
AEIIB
PMFND
7TK
7XB
8FE
8FH
8FK
K9.
LK8
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
ID FETCH-LOGICAL-c645t-9d12da9549e21aa5a03d4cdc20b104f240a3ed43bcfc0a6184b32b55561ac7f43
IEDL.DBID 7X7
ISSN 1359-4184
1476-5578
IngestDate Thu Aug 21 13:19:39 EDT 2025
Mon Jul 21 10:32:51 EDT 2025
Fri Jul 25 09:04:27 EDT 2025
Tue Jun 17 21:47:08 EDT 2025
Tue Jun 10 20:37:11 EDT 2025
Mon Jul 21 05:58:29 EDT 2025
Tue Jul 01 00:21:44 EDT 2025
Thu Apr 24 22:50:20 EDT 2025
Fri Feb 21 02:39:32 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License This work is licensed under a Creative Commons Attribution 3.0 Unported License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/3.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c645t-9d12da9549e21aa5a03d4cdc20b104f240a3ed43bcfc0a6184b32b55561ac7f43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
OpenAccessLink https://www.nature.com/articles/mp.2014.66
PMID 25048005
PQID 1650977978
PQPubID 44096
PageCount 14
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4320288
proquest_miscellaneous_1652439761
proquest_journals_1650977978
gale_infotracmisc_A401215315
gale_infotracacademiconefile_A401215315
pubmed_primary_25048005
crossref_primary_10_1038_mp_2014_66
crossref_citationtrail_10_1038_mp_2014_66
springer_journals_10_1038_mp_2014_66
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2015-02-01
PublicationDateYYYYMMDD 2015-02-01
PublicationDate_xml – month: 02
  year: 2015
  text: 2015-02-01
  day: 01
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
– name: New York
PublicationTitle Molecular psychiatry
PublicationTitleAbbrev Mol Psychiatry
PublicationTitleAlternate Mol Psychiatry
PublicationYear 2015
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Fisman (CR211) 1975; 126
Krystal, Anand, Moghaddam (CR45) 2002; 59
Muller, Schwarz (CR107) 2006; 10
Lavoie, Murray, Deppen, Knyazeva, Berk, Boulat (CR134) 2008; 33
Bloemen, Gleich, de Koning, da Silva Alvis, de Haan, Linszen (CR193) 2011; 70
Keshavan, Dick, Diwadkar, Montrose, Prasad, Stanley (CR65) 2009; 115
Schmitt, Meisenzahl, Frodl, La Fougère, Hahn, Möller (CR184) 2005; 19
Bustillo, Rowland, Mullins, Jung, Chen, Qualls (CR75) 2010; 15
Amminger, Schäfer, Papageorgiou, Klier, Cotton, Harrigan (CR135) 2010; 67
Schneider, Kwan (CR139) 2013; 14
Miller, Buckley, Seabolt, Mellor, Kirkpatrick (CR102) 2011; 70
Howes, Bose, Turkheimer, Valli, Egerton, Stahl (CR161) 2011; 16
Yang, Yu, Yeh, Chiu, Chen, Lee (CR191) 2004; 161
Takano, Arakawa, Ito, Tateno, Takahashi, Matsumoto (CR98) 2010; 13
Fusar-Poli, Deste, Smieskova, Barlati, Yung, Howes (CR25) 2012; 69
Luber, Steffener, Tucker, Habeck, Peterchev, Deng (CR149) 2013; 36
Abdel-Baki, Brazzini-Poisson, Marois, Letendre, Karelis (CR143) 2013; 149
Vuksan-Cusa, Sagud, Jakovljevic, Peles, Jaksic, Mihaljevic (CR154) 2013; 67
van Haren, Cahn, Hulshoff Pol, Kahn (CR9) 2013; 37
Hietala, Syvälahti, Vuorio, Räkköläinen, Bergman, Haaparanta (CR171) 1995; 346
Fusar-Poli, Broome, Matthiasson, Woolley, Mechelli, Johns (CR70) 2011; 37
Steiner, Bernstein, Bielau, Farkas, Winter, Dobrowolny (CR219) 2008; 42
Feinberg (CR55) 1982; 17
Haijma, Van Haren, Cahn, Koolschijn, Hulshoff Pol, Kahn (CR2) 2013; 39
Andreasen, Liu, Ziebell, Vora, Ho (CR12) 2013; 170
Lane, Liu, Huang, Chang, Liau, Perng (CR126) 2008; 63
De la Fuente-Sandoval, León-Ortiz, Azcárraga, Stephano, Favila, Díaz-Galvis (CR198) 2013; 70
Simon, Borgwardt, Riecher-Rössler, Velthorst, de Haan, Fusar-Poli (CR29) 2013; 209
Kato, Monji, Hashioka, Kanba (CR115) 2007; 92
Zakharyan, Boyajyan (CR151) 2014; 15
Sgouros, Hockley, Goldin, Wake, Natarajan (CR4) 1999; 91
Mossaheb, Schäfer, Schlögelhofer, Klier, Cotton, McGorry, Amminger (CR136) 2013; 148
Agid, Arenovich, Sajeev, Zipursky, Kapur, Foussias (CR121) 2011; 72
Graff-Guerrero, Mizrahi, Agid, Marcon, Barsoum, Rusjan (CR170) 2009; 34
Kuswanto, Teh, Lee, Sim (CR15) 2012; 10
Karlsgodt, Niendam, Bearden, Cannon (CR33) 2009; 66
Karlsson, Farde, Halldin, Sedvall (CR174) 2002; 159
Fillman, Cloonan, Miller, Weickert (CR114) 2013; 18
Roberts, Colter, Lofthouse, Johnstone, Crow (CR217) 1987; 22
Théberge, Williamson, Aoyama, Drost, Manchanda, Malla (CR203) 2007; 191
Mateos, Lomeña, Parellada, Font, Fernandez, Pavia (CR179) 2005; 181
Coyle (CR109) 2013; 70
Doorduin, de Vries, Willemsen, de Groot, Dierckx, Klein (CR97) 2009; 50
Nozaki, Kato, Takano, Ito, Takahashi, Arakawa (CR182) 2009; 108
Rao, Kim, Harry, Rapoport, Reese (CR215) 2013; 147
Curley, Arion, Volk, Asafu-Adjei, Sampson, Fish (CR57) 2011; 168
Insel (CR131) 2010; 468
Allen, Chaddock, Howes, Egerton, Seal, Fusar-Poli (CR155) 2012; 38
van Haren, Schnack, Cahn, van den Heuvel, Lepage, Collins (CR10) 2011; 68
McAllister (CR89) 2014; 75
Wierzba-Bobrowicz, Lewandowska, Lechowicz, Stepień, Pasennik (CR225) 2005; 43
Stevens, Casanova, Bigelow (CR222) 1988; 24
Howes, Kapur (CR40) 2009; 35
Corripio, Escartí, Portella, Pérez, Grasa, Sauras (CR167) 2011; 21
Simon, Grädel, Cattapan-Ludewig, Gruber, Ballinari, Roth (CR28) 2012; 142
de la Fuente-Sandoval, León-Ortiz, Azcárraga, Favila, Stephano, Graff- Guerrero (CR67) 2013; 16
Scheewe, van Haren, Sarkisyan, Schnack, Brouwer, de Glint (CR144) 2013; 23
O’Rahilly, R Müller (CR3) 1992
de Jesus, Favalli, Hoppenbrouwers, Barr, Chen, Fitzgerald (CR147) 2013; 124
Bloemen, de Koning, Gleich, Meijer, de Haan, Linszen (CR156) 2013; 23
Valli, Stone, Mechelli, Bhattacharyya, Raffin, Allen (CR196) 2011; 69
Lin, Wood, Nelson, Brewer, Spiliotacopoulos, Bruxner (CR35) 2011; 132
van Berckel, Bossong, Boellaard, Kloet, Schuitemaker, Caspers (CR96) 2008; 64
Yoon, Maddock, Rokem, Silver, Minzenberg, Ragland (CR83) 2010; 30
Bustillo, Chen, Jones, Lemke, Abbott, Qualls (CR81) 2014; 71
Kato, Monji, Mizoguchi, Hashioka, Horikawa, Seki, Kasai, Utsumi, Kanba (CR116) 2011; 11
Gajwani, Patterson, Birchwood (CR26) 2013; 52
van Oel, Sitskoorn, Cremer, Kahn (CR36) 2002; 28
Dickerson, Stallings, Origoni, Boronow, Yolken (CR152) 2007; 93
Vinkers, Mirza, Olivier, Kahn (CR130) 2010; 19
Harrison, Weinberger (CR47) 2005; 10
Samuelsson, Jennische, Hansson, Holmäng (CR51) 2006; 290
Schmitt, Steyskal, Bernstein, Schneider-Axmann, Parlapani, Schaeffer (CR24) 2009; 117
de Jong, van Eijk, Zeegers, Strengman, Janson, Veldink (CR86) 2012; 20
Wierzba-Bobrowicz, Lewandowska, Kosno-Kruszewska, Lechowicz, Pasennik, Schmidt-Sidor (CR224) 2004; 42
Bartha, al-Semaan, Williamson, Drost, Malla, Carr (CR197) 1999; 45
Steiner, Mawrin, Ziegeler, Bielau, Ullrich, Bernstein (CR218) 2006; 112
van Haren, Cahn, Hulshoff Pol, Kahn (CR18) 2012; 26
Tibbo, Hanstock, Valiakalayil, Allen (CR64) 2004; 161
Purdon, Valiakalayil, Hanstock, Seres, Tibbo (CR195) 2008; 99
Yoo, Yeon, Choi, Kang, Lee, Shin (CR71) 2009; 111
Smith, Li, Garbett, Mirnics, Patterson (CR105) 2007; 27
Roberts, Colter, Lofthouse, Bogerts, Zech, Crow (CR216) 1986; 21
Meyer, Feldon (CR110) 2009; 204
Hahn, Wang, Cho, Talbot, Gur, Berrettini (CR48) 2006; 12
Blakemore (CR5) 2012; 61
Stevens (CR85) 1982; 39
Wood, Berger, Wellard, Proffitt, McConchie, Velakoulis (CR204) 2008; 102
CR129
Hoff, Svetina, Shields, Stewart, DeLisi (CR59) 2005; 78
Goto, Yoshimura, Moriya, Kakeda, Ueda, Ikenouchi-Sugita (CR82) 2009; 112
Bustillo, Chen, Gasparovic, Mullins, Caprihan, Qualls (CR79) 2011; 69
Stone, Day, Tsagaraki, Valli, McLean, Lythgoe (CR69) 2009; 66
Canetta, Brown (CR92) 2012; 3
Monji, Kato, Kanba (CR100) 2009; 63
Corripio, Pérez, Catafau, Mena, Carrió, Alvarez (CR166) 2006; 29
Huh, Boulanger, Du, Riquelme, Brotz, Shatz (CR90) 2000; 290
Robinson (CR119) 2010; 15
Owen, Setiawan, Li, McCabe, Matthews (CR54) 2004; 71
Feigenson, Kusnecov, Silverstein (CR103) 2014; 38
Suridjan, Rusjan, Addington, Wilson, Houle, Mizrahi (CR162) 2013; 38
Steiner, Bielau, Brisch, Danos, Ullrich, Mawrin (CR220) 2008; 42
Singh, Singh (CR122) 2011; 25
Pajonk, Wobrock, Gruber, Scherk, Berner, Kaizl (CR145) 2010; 67
Tandon, Bolo, Sanghavi, Mathew, Francis, Stanley (CR68) 2013; 148
Stevens, Altshuler, Bogerts, Falkai (CR221) 1988; 24
Fromer, Pocklington, Kavanagh, William, Dwyer, Gormley (CR49) 2014; 506
Kurumaji, Wakai, Toru (CR212) 1997; 104
Lehrer, Christian, Kirbas, Chiang, Sidhu, Short (CR177) 2010; 122
Mateos, Lomeña, Parellada, Font, Fernández, Pavia (CR180) 2006; 25
Galińska, Szulc, Tarasów, Kubas, Dzienis, Czernikiewicz (CR78) 2009; 15
Fusar-Poli, Nelson, Valmaggia, Yung, McGuire (CR27) 2014; 40
Schmitt, Dresel, Frodl, la Fougère, Boerner, Hahn (CR188) 2012; 262
Egerton, Chaddock, Winton-Brown, Bloomfield, Bhattacharyya, Allen (CR157) 2013; 74
Narayan, Tang, Head, Gilmartin, Sutcliffe, Dean (CR101) 2008; 1239
Hashimoto, Malchow, Falkai, Schmitt (CR124) 2013; 263
El-Khodor, Flores, Srivastava, Boksa (CR52) 2004; 54
Hagberg, Gressens, Mallard (CR95) 2012; 71
Di Raimondo, Tuttolomondo, Buttà, Casuccio, Giarrusso, Miceli (CR142) 2013; 67
Safont, Corripio, Escartí, Portella, Pérez, Ferrer (CR183) 2011; 129
Daskalakis, Möller, Christensen, Fitzgerald, Gunraj, Chen (CR146) 2006; 174
Talvik, Nordström, Olsson, Halldin, Farde (CR189) 2003; 6
Hietala, Syvälahti, Vilkman, Vuorio, Räkköläinen, Bergman (CR172) 1999; 35
Steiner, Walter, Glanz, Sarnyai, Bernstein, Vielhaber (CR94) 2013; 70
Shatz (CR91) 2009; 64
Steen, Mull, McClure, Hamer, Lieberman (CR21) 2006; 188
Yasuno, Suhara, Okubo, Sudo, Inoue, Ichimiya (CR192) 2004; 161
Olbrich, Valerius, Rüsch, Buchert, Thiel, Hennig (CR201) 2008; 9
Papadia, Soriano, Leveille, Martel, Dakin, Hansen (CR104) 2008; 11
Bruton, Crow, Frith, Johnstone, Owens, Roberts (CR207) 1990; 20
Fillman, Cloonan, Catts, Miller, Wong, McCrossin (CR210) 2013; 18
Bach, Simpson, Kahn, Marshall, Kandel, Kellendonk (CR42) 2008; 105
Carmeli, Knyazeva, Cuénod, Do (CR133) 2012; 7
de la Fuente-Sandoval, León-Ortiz, Favila, Stephano, Mamo, Ramírez- Bermúdez (CR66) 2011; 36
Lewis, Hashimoto, Volk (CR56) 2005; 6
Zheng, Hwang, Ock, Lee, Lee, Suk (CR117) 2008; 107
Hyde, Lipska, Ali, Mathew, Law, Metitiri (CR58) 2011; 31
Berk, Malhi, Gray, Dean (CR137) 2013; 34
Bonoldi, Howes (CR39) 2013; 68
Talvik, Nordström, Okubo, Olsson, Borg, Halldin (CR190) 2006; 148
Tayoshi, Nakataki, Sumitani, Taniguchi, Shibuya-Tayoshi, Numata (CR84) 2010; 117
Wood, Yücel, Wellard, Harrison, Clarke, Fornito (CR77) 2007; 94
Anticevic, Gancsos, Murray, Repovs, Driesen, Ennis (CR43) 2012; 109
Heresco-Levy, Javitt (CR123) 2004; 66
Abi-Dargham, Xu, Thompson, Gil, Kegeles, Urban (CR164) 2012; 26
Snyder, Gao (CR46) 2013; 7
Schmitt, Frodl, Dresel, la Fougère, Bottlender, Koutsouleris (CR185) 2006; 256
Radewicz, Garey, Gentleman, Reynolds (CR214) 2000; 59
Corvin, Morris (CR88) 2014; 75
Arnold, Trojanowski, Gur, Blackwell, Han, Choi (CR205) 1998; 55
Busse, Busse, Schiltz, Bielau, Gos, Brisch (CR208) 2012; 26
Vita, De Peri, Deste, Sacchetti (CR17) 2012; 2
Schmaal, Berk, Hulstijn, Cousijn, Wiers, van den Brink (CR138) 2011; 17
Nasrallah, McCalley-Whitters, Bigelow, Rauscher (CR213) 1983; 8
Benros, Nielsen, Nordentoft, Eaton, Dalton, Mortensen (CR93) 2011; 168
Chauveau, Van Camp, Dollé, Kuhnast, Hinnen, Damont (CR99) 2009; 50
Demjaha, Murray, McGuire, Kapur, Howes (CR113) 2012; 169
Fusar-Poli, Howes, Allen, Broome, Valli, Asselin (CR159) 2011; 16
Dickerson, Stallings, Origoni, Vaughan, Khushalani, Yang (CR153) 2013; 143
Floresco, Todd, Grace (CR60) 2001; 21
Schmitt, la Fougère, Dresel, Frodl, Hahn, Möller (CR186) 2008; 101
Cahn, van Haren, Hulshoff Pol, Schnack, Caspers, Laponder (CR8) 2006; 189
Behrens, Ali, Dugan (CR106) 2008; 28
Sommer, van Westrhenen, Begemann, de Witte, Leucht, Kahn (CR132) 2014; 40
Laakso, Vilkman, Alakare, Haaparanta, Bergman, Solin (CR175) 2000; 157
Niendam, Bearden, Johnson, McKinley, Loewy, O'Brien (CR34) 2006; 84
Falke, Han, Arnold (CR209) 2000; 93
Bayer, Buslei, Havas, Falkai (CR206) 1999; 271
Rowland, Kontson, West, Edden, Zhu, Wijtenburg (CR62) 2013; 39
Togo, Akiyama, Kondo, Ikeda, Kato, Iseki (CR223) 2000; 885
Buchsbaum, Christian, Lehrer, Narayanan, Shi, Mantil (CR165) 2006; 85
Mayer, Westbrook, Vyklický (CR108) 19
MC Hsiao (BFmp201466_CR173) 2003; 65
I Bonoldi (BFmp201466_CR39) 2013; 68
JH Yoon (BFmp201466_CR83) 2010; 30
BJ Kinon (BFmp201466_CR128) 2011; 31
O Howes (BFmp201466_CR161) 2011; 16
TW Scheewe (BFmp201466_CR144) 2013; 23
JT Coyle (BFmp201466_CR109) 2013; 70
P Tibbo (BFmp201466_CR64) 2004; 161
R Gajwani (BFmp201466_CR26) 2013; 52
A Abi-Dargham (BFmp201466_CR164) 2012; 26
T Wierzba-Bobrowicz (BFmp201466_CR224) 2004; 42
K Radewicz (BFmp201466_CR214) 2000; 59
D Owen (BFmp201466_CR54) 2004; 71
GJE Schmitt (BFmp201466_CR184) 2005; 19
CJ Shatz (BFmp201466_CR91) 2009; 64
I Valli (BFmp201466_CR196) 2011; 69
GW Roberts (BFmp201466_CR216) 1986; 21
P Fusar-Poli (BFmp201466_CR25) 2012; 69
HE Hulshoff Pol (BFmp201466_CR6) 2008; 34
MS Buchsbaum (BFmp201466_CR165) 2006; 85
F Dickerson (BFmp201466_CR153) 2013; 143
CJ Bruton (BFmp201466_CR207) 1990; 20
JR Bustillo (BFmp201466_CR75) 2010; 15
I Feinberg (BFmp201466_CR55) 1982; 17
K Hashimoto (BFmp201466_CR124) 2013; 263
B Luber (BFmp201466_CR149) 2013; 36
AK McAllister (BFmp201466_CR89) 2014; 75
A Egerton (BFmp201466_CR112) 2012; 18
SG Fillman (BFmp201466_CR210) 2013; 18
AM Samuelsson (BFmp201466_CR51) 2006; 290
J Théberge (BFmp201466_CR74) 2007; 61
BY Glenthoj (BFmp201466_CR168) 2006; 60
N Tandon (BFmp201466_CR68) 2013; 148
PJ Harrison (BFmp201466_CR47) 2005; 10
GJE Schmitt (BFmp201466_CR186) 2008; 101
HE Hulshoff Pol (BFmp201466_CR7) 2004; 55
B Luber (BFmp201466_CR148) 2007; 1128
TA Niendam (BFmp201466_CR34) 2006; 84
C Carmeli (BFmp201466_CR133) 2012; 7
P Ohrmann (BFmp201466_CR200) 2007; 41
C Kaur (BFmp201466_CR53) 2006; 98
LT Zheng (BFmp201466_CR117) 2008; 107
ST Patil (BFmp201466_CR127) 2007; 13
CN Kuswanto (BFmp201466_CR15) 2012; 10
NE van Haren (BFmp201466_CR10) 2011; 68
HY Lane (BFmp201466_CR126) 2008; 63
JJ Mateos (BFmp201466_CR180) 2006; 25
NE van Haren (BFmp201466_CR18) 2012; 26
SJ Wood (BFmp201466_CR30) 2013; 58
SE Purdon (BFmp201466_CR195) 2008; 99
A Corvin (BFmp201466_CR88) 2014; 75
OD Howes (BFmp201466_CR37) 2009; 66
A Anticevic (BFmp201466_CR43) 2012; 109
BFmp201466_CR72
HE Hulshoff Pol (BFmp201466_CR20) 2008; 34
R Bartha (BFmp201466_CR73) 1997; 54
O’Rahilly (BFmp201466_CR3) 1992
TA Bayer (BFmp201466_CR206) 1999; 271
W Cahn (BFmp201466_CR8) 2006; 189
BC Ho (BFmp201466_CR11) 2011; 68
ML Schneider (BFmp201466_CR139) 2013; 14
JR Bustillo (BFmp201466_CR79) 2011; 69
J Théberge (BFmp201466_CR202) 2002; 159
M Wang (BFmp201466_CR50) 2013; 77
GS Huh (BFmp201466_CR90) 2000; 290
A Vita (BFmp201466_CR17) 2012; 2
FG Pajonk (BFmp201466_CR145) 2010; 67
J Hietala (BFmp201466_CR171) 1995; 346
SJ Blakemore (BFmp201466_CR5) 2012; 61
R Bartha (BFmp201466_CR197) 1999; 45
A Lin (BFmp201466_CR35) 2011; 132
CG Hahn (BFmp201466_CR48) 2006; 12
RS Kahn (BFmp201466_CR1) 2013; 70
S Busse (BFmp201466_CR208) 2012; 26
P Allen (BFmp201466_CR155) 2012; 38
BFmp201466_CR129
F Dickerson (BFmp201466_CR152) 2007; 93
JH Krystal (BFmp201466_CR45) 2002; 59
OJN Bloemen (BFmp201466_CR193) 2011; 70
J Hirvonen (BFmp201466_CR160) 2005; 62
OD Howes (BFmp201466_CR40) 2009; 35
NE van Haren (BFmp201466_CR9) 2013; 37
TL Schwartz (BFmp201466_CR44) 2012; 18
JJ Mateos (BFmp201466_CR179) 2005; 181
BF El-Khodor (BFmp201466_CR52) 2004; 54
T Reis Marques (BFmp201466_CR14) 2014; 137
A Kurumaji (BFmp201466_CR212) 1997; 104
CJ van Oel (BFmp201466_CR36) 2002; 28
J Steiner (BFmp201466_CR220) 2008; 42
J Steiner (BFmp201466_CR94) 2013; 70
CH Vinkers (BFmp201466_CR130) 2010; 19
MS Keshavan (BFmp201466_CR65) 2009; 115
H Stefansson (BFmp201466_CR87) 2009; 460
B Galińska (BFmp201466_CR78) 2009; 15
A Marsman (BFmp201466_CR80) 2013; 39
M Talvik (BFmp201466_CR189) 2003; 6
J Radua (BFmp201466_CR16) 2012; 36
D Di Raimondo (BFmp201466_CR142) 2013; 67
S Lavoie (BFmp201466_CR134) 2008; 33
DA Lewis (BFmp201466_CR56) 2005; 6
P Fusar-Poli (BFmp201466_CR158) 2010; 67
JR Bustillo (BFmp201466_CR81) 2014; 71
SE Canetta (BFmp201466_CR92) 2012; 3
A Graff-Guerrero (BFmp201466_CR169) 2009; 66
AE Simon (BFmp201466_CR28) 2012; 142
MA Snyder (BFmp201466_CR46) 2013; 7
N Mossaheb (BFmp201466_CR136) 2013; 148
DC Goff (BFmp201466_CR125) 2008; 33
A Graff-Guerrero (BFmp201466_CR170) 2009; 34
N Muller (BFmp201466_CR107) 2006; 10
J Steiner (BFmp201466_CR219) 2008; 42
P Fusar-Poli (BFmp201466_CR27) 2014; 40
A Abdel-Baki (BFmp201466_CR143) 2013; 149
TM Hyde (BFmp201466_CR58) 2011; 31
F Chauveau (BFmp201466_CR99) 2009; 50
S Potvin (BFmp201466_CR150) 2008; 63
SB Floresco (BFmp201466_CR60) 2001; 21
KA Feigenson (BFmp201466_CR103) 2014; 38
SV Haijma (BFmp201466_CR2) 2013; 39
ME Benros (BFmp201466_CR93) 2011; 168
A Laakso (BFmp201466_CR175) 2000; 157
A Mechelli (BFmp201466_CR31) 2011; 68
C de la Fuente-Sandoval (BFmp201466_CR67) 2013; 16
U Heresco-Levy (BFmp201466_CR123) 2004; 66
I Suridjan (BFmp201466_CR162) 2013; 38
JS Rao (BFmp201466_CR215) 2013; 147
TW Scheewe (BFmp201466_CR140) 2013; 127
JA Stanley (BFmp201466_CR76) 1996; 22
RC Mandl (BFmp201466_CR13) 2013; 34
J Stevens (BFmp201466_CR222) 1988; 24
M Fromer (BFmp201466_CR49) 2014; 506
T Togo (BFmp201466_CR223) 2000; 885
M Berk (BFmp201466_CR137) 2013; 34
S Radom-Aizik (BFmp201466_CR141) 2014; 39
RG Steen (BFmp201466_CR21) 2006; 188
DG Robinson (BFmp201466_CR120) 1999; 156
L Schmaal (BFmp201466_CR138) 2011; 17
I Corripio (BFmp201466_CR166) 2006; 29
ME Bach (BFmp201466_CR42) 2008; 105
O Pasternak (BFmp201466_CR111) 2012; 32
SE Smith (BFmp201466_CR105) 2007; 27
SP Singh (BFmp201466_CR122) 2011; 25
TA Kato (BFmp201466_CR116) 2011; 11
S de Jong (BFmp201466_CR86) 2012; 20
J Lavalaye (BFmp201466_CR176) 2001; 47
AA Curley (BFmp201466_CR57) 2011; 168
D Robinson (BFmp201466_CR119) 2010; 15
GJE Schmitt (BFmp201466_CR187) 2009; 173
NE van Haren (BFmp201466_CR19) 2008; 23
VL Friedrich Jr (BFmp201466_CR23) 2003; 53
J Hietala (BFmp201466_CR172) 1999; 35
DS Lehrer (BFmp201466_CR177) 2010; 122
A Abi-Dargham (BFmp201466_CR163) 2002; 22
KH Karlsgodt (BFmp201466_CR33) 2009; 66
LH Lindström (BFmp201466_CR178) 1999; 46
Q Wang (BFmp201466_CR22) 2013; 43
GP Amminger (BFmp201466_CR135) 2010; 67
SE Arnold (BFmp201466_CR205) 1998; 55
YK Yang (BFmp201466_CR191) 2004; 161
SJ Wood (BFmp201466_CR204) 2008; 102
E Falke (BFmp201466_CR209) 2000; 93
AE Simon (BFmp201466_CR29) 2013; 209
TR Insel (BFmp201466_CR131) 2010; 468
TT Winton-Brown (BFmp201466_CR41) 2014; 37
S Nozaki (BFmp201466_CR182) 2009; 108
NC Andreasen (BFmp201466_CR12) 2013; 170
S Sgouros (BFmp201466_CR4) 1999; 91
ZJ Daskalakis (BFmp201466_CR146) 2006; 174
GW Roberts (BFmp201466_CR217) 1987; 22
SJ Wood (BFmp201466_CR77) 2007; 94
A Demjaha (BFmp201466_CR113) 2012; 169
SY Yoo (BFmp201466_CR71) 2009; 111
N Goto (BFmp201466_CR82) 2009; 112
JR Stevens (BFmp201466_CR85) 1982; 39
P Fusar-Poli (BFmp201466_CR194) 2011; 68
IE Sommer (BFmp201466_CR132) 2014; 40
P Ohrmann (BFmp201466_CR199) 2005; 73
S Papadia (BFmp201466_CR104) 2008; 11
RS Kahn (BFmp201466_CR118) 2008; 371
C de la Fuente-Sandoval (BFmp201466_CR66) 2011; 36
I Corripio (BFmp201466_CR167) 2011; 21
A Adell (BFmp201466_CR61) 2012; 38
S Tayoshi (BFmp201466_CR84) 2010; 117
GJE Schmitt (BFmp201466_CR188) 2012; 262
J Doorduin (BFmp201466_CR97) 2009; 50
DR de Jesus (BFmp201466_CR147) 2013; 124
J Théberge (BFmp201466_CR203) 2007; 191
M Talvik (BFmp201466_CR190) 2006; 148
AL Hoff (BFmp201466_CR59) 2005; 78
F Yasuno (BFmp201466_CR192) 2004; 161
H Hagberg (BFmp201466_CR95) 2012; 71
LM Rowland (BFmp201466_CR63) 2005; 162
C De la Fuente-Sandoval (BFmp201466_CR198) 2013; 70
BN van Berckel (BFmp201466_CR96) 2008; 64
S Narayan (BFmp201466_CR101) 2008; 1239
P Fusar-Poli (BFmp201466_CR159) 2011; 16
G Safont (BFmp201466_CR183) 2011; 129
OD Howes (BFmp201466_CR38) 2011; 168
LM Rowland (BFmp201466_CR62) 2013; 39
HA Nasrallah (BFmp201466_CR213) 1983; 8
SG Fillman (BFmp201466_CR114) 2013; 18
BFmp201466_CR181
U Meyer (BFmp201466_CR110) 2009; 204
O Agid (BFmp201466_CR121) 2011; 72
M Fisman (BFmp201466_CR211) 1975; 126
T Kato (BFmp201466_CR115) 2007; 92
B Vuksan-Cusa (BFmp201466_CR154) 2013; 67
R Zakharyan (BFmp201466_CR151) 2014; 15
BJ Miller (BFmp201466_CR102) 2011; 70
P Karlsson (BFmp201466_CR174) 2002; 159
L Samartzis (BFmp201466_CR32) 2014; 24
T Wierzba-Bobrowicz (BFmp201466_CR225) 2005; 43
J Steiner (BFmp201466_CR218) 2006; 112
P Fusar-Poli (BFmp201466_CR70) 2011; 37
MM Behrens (BFmp201466_CR106) 2008; 28
GJE Schmitt (BFmp201466_CR185) 2006; 256
A Egerton (BFmp201466_CR157) 2013; 74
HM Olbrich (BFmp201466_CR201) 2008; 9
ML Mayer (BFmp201466_CR108) 1988; 60
A Monji (BFmp201466_CR100) 2009; 63
OJN Bloemen (BFmp201466_CR156) 2013; 23
JM Stone (BFmp201466_CR69) 2009; 66
A Schmitt (BFmp201466_CR24) 2009; 117
A Takano (BFmp201466_CR98) 2010; 13
CD Stevens (BFmp201466_CR221) 1988; 24
References_xml – volume: 1239
  start-page: 235
  year: 2008
  end-page: 248
  ident: CR101
  article-title: Molecular profiles of schizophrenia in the CNS at different stages of illness
  publication-title: Brain Res
  doi: 10.1016/j.brainres.2008.08.023
– volume: 67
  start-page: 320
  year: 2013
  end-page: 325
  ident: CR154
  article-title: Association between C-reactive protein and homocysteine with the subcomponents of metabolic syndrome in stable patients with bipolar disorder and schizophrenia
  publication-title: Nord J Psychiatry
  doi: 10.3109/08039488.2012.745601
– volume: 159
  start-page: 761
  year: 2002
  end-page: 767
  ident: CR174
  article-title: PET study of D(1) dopamine receptor binding in neuroleptic-naive patients with schizophrenia
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.159.5.761
– volume: 115
  start-page: 88
  year: 2009
  end-page: 93
  ident: CR65
  article-title: Striatal metabolic alterations in non-psychotic adolescent offspring at risk for schizophrenia: a (1)H spectroscopy study
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2009.08.012
– volume: 71
  start-page: 444
  year: 2012
  end-page: 457
  ident: CR95
  article-title: Inflammation during fetal and neonatal life: implications for neurologic and neuropsychiatric disease in children and adults
  publication-title: Ann Neurol.
  doi: 10.1002/ana.22620
– volume: 188
  start-page: 510
  year: 2006
  end-page: 518
  ident: CR21
  article-title: Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies
  publication-title: Br J Psychiatry
  doi: 10.1192/bjp.188.6.510
– volume: 38
  start-page: 1040
  year: 2012
  end-page: 9
  ident: CR155
  article-title: Abnormal relationship between medial temporal lobe and subcortical dopamine function in people with an ultra high risk for psychosis
  publication-title: Schizophr Bull.
  doi: 10.1093/schbul/sbr017
– volume: 52
  start-page: 424
  year: 2013
  end-page: 437
  ident: CR26
  article-title: Attachment: developmental pathways to affective dysregulation in young people at ultra-high risk of developing psychosis
  publication-title: Br J Clin Psychol
  doi: 10.1111/bjc.12027
– volume: 54
  start-page: 138
  year: 2004
  end-page: 146
  ident: CR52
  article-title: Effects of birth insult and stress at adulthood on excitatory amino acid receptors in adult rat brain
  publication-title: Synapse
  doi: 10.1002/syn.20073
– volume: 66
  start-page: 562
  year: 2009
  end-page: 569
  ident: CR33
  article-title: White matter integrity and prediction of social and role functioning in subjects at ultra-high risk for psychosis
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2009.03.013
– volume: 62
  start-page: 371
  year: 2005
  end-page: 378
  ident: CR160
  article-title: Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.62.4.371
– volume: 24
  start-page: 727
  year: 1988
  end-page: 731
  ident: CR222
  article-title: Gliosis in schizophrenia
  publication-title: Biol Psychiatry
  doi: 10.1016/0006-3223(88)90154-0
– volume: 31
  start-page: 349
  year: 2011
  end-page: 355
  ident: CR128
  article-title: A multicenter, inpatient, phase 2, double-blind, placebocontrolled dose-ranging study of LY2140023 monohydrate in patients with DSM-IV schizophrenia
  publication-title: J Clin Psychopharmacol
  doi: 10.1097/JCP.0b013e318218dcd5
– volume: 33
  start-page: 2187
  year: 2008
  end-page: 2199
  ident: CR134
  article-title: Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1301624
– volume: 39
  start-page: 121
  year: 2014
  end-page: 129
  ident: CR141
  article-title: Impact of brief exercise on circulating monocyte gene and microRNA expression: Implications for atherosclerotic vascular disease
  publication-title: Brain Behav Immun
  doi: 10.1016/j.bbi.2014.01.003
– volume: 67
  start-page: 1247
  year: 2013
  end-page: 1253
  ident: CR142
  article-title: Metabolic and anti-inflammatory effects of a home-based programme of aerobic physical exercise
  publication-title: Int J Clin Pract
  doi: 10.1111/ijcp.12269
– volume: 12
  start-page: 824
  year: 2006
  end-page: 828
  ident: CR48
  article-title: Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia
  publication-title: Nat Med
  doi: 10.1038/nm1418
– volume: 75
  start-page: 276
  year: 2014
  end-page: 283
  ident: CR88
  article-title: Genome-wide association Studies: Findings at the major histo- compatibility complex locus in psychosis
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2013.09.018
– volume: 75
  start-page: 262
  year: 2014
  end-page: 268
  ident: CR89
  article-title: Major Histocompatibility Complex I in Brain Development and Schizophrenia
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2013.10.003
– volume: 94
  start-page: 328
  year: 2007
  end-page: 331
  ident: CR77
  article-title: Evidence for neuronal dysfunction in the anterior cingulate of patients with schizophrenia: a proton magnetic resonance spectroscopy study at 3 T
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2007.05.008
– volume: 93
  start-page: 103
  year: 2000
  end-page: 110
  ident: CR209
  article-title: Absence of neurodegeneration in the thalamus and caudate of elderly patients with schizophrenia
  publication-title: Psychiatry Res
  doi: 10.1016/S0165-1781(00)00104-9
– volume: 34
  start-page: 167
  year: 2013
  end-page: 177
  ident: CR137
  article-title: The promise of N-acetylcysteine in neuropsychiatry
  publication-title: Trends Pharmacol Sci
  doi: 10.1016/j.tips.2013.01.001
– volume: 42
  start-page: 868
  year: 2008
  end-page: 876
  ident: CR219
  article-title: S100B-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: a morphometric study
  publication-title: J Psychiatr Res
  doi: 10.1016/j.jpsychires.2007.10.001
– volume: 78
  start-page: 27
  year: 2005
  end-page: 34
  ident: CR59
  article-title: Ten year longitudinal study of neuropsychological functioning subsequent to a first episode of schizophrenia
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2005.05.010
– volume: 148
  start-page: 59
  year: 2013
  end-page: 66
  ident: CR68
  article-title: Brain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2013.05.024
– volume: 16
  start-page: 67
  year: 2011
  end-page: 75
  ident: CR159
  article-title: Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis
  publication-title: Mol. Psychiatry
  doi: 10.1038/mp.2009.108
– volume: 15
  start-page: 629
  year: 2010
  end-page: 636
  ident: CR75
  article-title: 1H-MRS at 4 tesla in minimally treated early schizophrenia
  publication-title: Mol Psychiatry.
  doi: 10.1038/mp.2009.121
– volume: 19
  start-page: 488
  year: 2005
  end-page: 493
  ident: CR184
  article-title: The striatal dopamine transporter in first-episode, drug-naive schizophrenic patients: evaluation by the new SPECT-ligand[99mTc]TRODAT-1
  publication-title: J Psychopharmacol (Oxford)
  doi: 10.1177/0269881105056530
– volume: 63
  start-page: 257
  year: 2009
  end-page: 265
  ident: CR100
  article-title: Cytokines and schizophrenia: Microglia hypothesis of schizophrenia
  publication-title: Psychiatry Clin Neurosci
  doi: 10.1111/j.1440-1819.2009.01945.x
– volume: 10
  start-page: 131
  year: 2006
  end-page: 148
  ident: CR107
  article-title: Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission
  publication-title: Neurotox Res
  doi: 10.1007/BF03033242
– volume: 142
  start-page: 108
  year: 2012
  end-page: 115
  ident: CR28
  article-title: Cognitive functioning in at-risk mental states for psychosis and 2-year clinical outcome
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2012.09.004
– volume: 13
  start-page: 1102
  year: 2007
  end-page: 1107
  ident: CR127
  article-title: Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial
  publication-title: Nat Med
  doi: 10.1038/nm1632
– volume: 70
  start-page: e1
  year: 2011
  end-page: 2
  ident: CR193
  article-title: Hippocampal glutamate levels and striatal dopamine D(2/3) receptor occupancy in subjects at ultra high risk of psychosis
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2010.11.030
– volume: 69
  start-page: 562
  year: 2012
  end-page: 571
  ident: CR25
  article-title: Cognitive functioning in prodromal psychosis: a meta-analysis
  publication-title: Arch Gen Psychiatry
– volume: 16
  start-page: 471
  year: 2013
  end-page: 475
  ident: CR67
  article-title: Striatal glutamate and the conversion to psychosis: a prospective 1H-MRS imaging study
  publication-title: Int J Neuropsychopharmacol
  doi: 10.1017/S1461145712000314
– volume: 117
  start-page: 395
  year: 2009
  end-page: 407
  ident: CR24
  article-title: Stereologic investigation of the posterior part of the hippocampus in schizophrenia
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-008-0430-y
– volume: 111
  start-page: 86
  year: 2009
  end-page: 93
  ident: CR71
  article-title: Proton magnetic resonance spectroscopy in subjects with high genetic risk of schizophrenia: investigation of anterior cingulate, dorsolateral prefrontal cortex and thalamus
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2009.03.036
– volume: 27
  start-page: 10695
  year: 2007
  end-page: 10702
  ident: CR105
  article-title: Maternal immune activation alters fetal brain development through interleukin-6
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.2178-07.2007
– volume: 22
  start-page: 1459
  year: 1987
  end-page: 1468
  ident: CR217
  article-title: Is there gliosis in schizophrenia? Investigation of the temporal lobe
  publication-title: Biol Psychiatry
  doi: 10.1016/0006-3223(87)90104-1
– volume: 168
  start-page: 1311
  year: 2011
  end-page: 1317
  ident: CR38
  article-title: Dopamine synthesis capacity before onset of psychosis: a prospective [18F]- DOPA PET imaging study
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.2011.11010160
– volume: 10
  start-page: 40
  year: 2005
  end-page: 68
  ident: CR47
  article-title: Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
  publication-title: Mol Psychiatry
  doi: 10.1038/sj.mp.4001558
– volume: 73
  start-page: 153
  year: 2005
  end-page: 157
  ident: CR199
  article-title: Evidence for glutamatergic neuronal dysfunction in the prefrontal cortex in chronic but not in first-episode patients with schizophrenia: a proton magnetic resonance spectroscopy study
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2004.08.021
– volume: 70
  start-page: 271
  year: 2013
  end-page: 278
  ident: CR94
  article-title: Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis
  publication-title: JAMA Psychiatry
  doi: 10.1001/2013.jamapsychiatry.86
– volume: 45
  start-page: 1403
  year: 1999
  end-page: 1411
  ident: CR197
  article-title: A short echo proton magnetic resonance spectroscopy study of the left mesial-temporal lobe in first-onset schizophrenic patients
  publication-title: Biol Psychiatry
  doi: 10.1016/S0006-3223(99)00007-4
– volume: 11
  start-page: 476
  year: 2008
  end-page: 487
  ident: CR104
  article-title: Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses
  publication-title: Nat Neurosci
  doi: 10.1038/nn2071
– volume: 91
  start-page: 617
  year: 1999
  end-page: 625
  ident: CR4
  article-title: Intracranial volume change in craniosynostosis
  publication-title: J Neurosurg
  doi: 10.3171/jns.1999.91.4.0617
– volume: 50
  start-page: 468
  year: 2009
  end-page: 476
  ident: CR99
  article-title: Comparative evaluation of the translocator protein radioligands 11C-DPA-713, 18F-DPA-714, and 11C-PK11195 in a rat model of acute neuroinflammation
  publication-title: J Nucl Med
  doi: 10.2967/jnumed.108.058669
– volume: 209
  start-page: 266
  year: 2013
  end-page: 272
  ident: CR29
  article-title: Moving beyond transition outcomes: Meta-analysis of remission rates in individuals at high clinical risk for psychosis
  publication-title: Psychiatry Res
  doi: 10.1016/j.psychres.2013.03.004
– volume: 15
  start-page: 4
  year: 2010
  end-page: 7
  ident: CR119
  article-title: First-episode schizophrenia
  publication-title: CNS Spectr
  doi: 10.1017/S1092852900027681
– volume: 14
  start-page: 776
  year: 2013
  end-page: 785
  ident: CR139
  article-title: Psychological need satisfaction, intrinsic motivation and affective response to exercise in adolescents
  publication-title: Psychol Sport Exerc
  doi: 10.1016/j.psychsport.2013.04.005
– volume: 161
  start-page: 1016
  year: 2004
  end-page: 1022
  ident: CR192
  article-title: Low dopamine d(2) receptor binding in subregions of the thalamus in schizophrenia
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.161.6.1016
– volume: 59
  start-page: 137
  year: 2000
  end-page: 150
  ident: CR214
  article-title: Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics
  publication-title: J Neuropathol Exp Neurol
  doi: 10.1093/jnen/59.2.137
– volume: 84
  start-page: 100
  year: 2006
  end-page: 111
  ident: CR34
  article-title: Neurocognitive performance and functional disability in the psychosis prodrome
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2006.02.005
– volume: 98
  start-page: 1200
  year: 2006
  end-page: 1216
  ident: CR53
  article-title: Hypoxic damage to the periventricular white matter in neonatal brain: role of vascular endothelial growth factor, nitric oxide and excitotoxicity
  publication-title: J Neurochem
  doi: 10.1111/j.1471-4159.2006.03964.x
– volume: 11
  start-page: 565
  year: 2011
  end-page: 574
  ident: CR116
  article-title: Anti-Inflammatory properties of antipsychotics microglia modulations: are antipsychotics a 'fire extinguisher' in the brain of schizophrenia?
  publication-title: Mini Rev Med Chem
  doi: 10.2174/138955711795906941
– volume: 36
  start-page: 857
  year: 2013
  end-page: 871
  ident: CR149
  article-title: Extended remediation of sleep deprived-induced working memory deficits using fMRI-guided transcranial magnetic stimulation
  publication-title: Sleep
  doi: 10.5665/sleep.2712
– volume: 28
  start-page: 401
  year: 2002
  end-page: 414
  ident: CR36
  article-title: School performance as a premorbid marker for schizophrenia: a twin study
  publication-title: Schizophr Bull
  doi: 10.1093/oxfordjournals.schbul.a006949
– volume: 137
  start-page: 172
  year: 2014
  end-page: 182
  ident: CR14
  article-title: White matter integrity as a predictor of response to treatment in first episode psychosis
  publication-title: Brain
  doi: 10.1093/brain/awt310
– volume: 69
  start-page: 19
  year: 2011
  end-page: 27
  ident: CR79
  article-title: Glutamate as a marker of cognitive function in schizophrenia: a proton spectroscopic imaging study at 4 Tesla
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2010.08.024
– volume: 37
  start-page: 2418
  year: 2013
  end-page: 2423
  ident: CR9
  article-title: Confounders of excessive brain volume loss in schizophrenia
  publication-title: Neurosci Biobehav Rev
  doi: 10.1016/j.neubiorev.2012.09.006
– volume: 35
  start-page: 549
  year: 2009
  end-page: 562
  ident: CR40
  article-title: The dopamine hypothesis of schizophrenia: version III—the final common pathway
  publication-title: Schizophr Bull
  doi: 10.1093/schbul/sbp006
– volume: 59
  start-page: 663
  year: 2002
  end-page: 664
  ident: CR45
  article-title: Effects of NMDA receptor antagonists: implications for the pathophysiology of schizophrenia
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.59.7.663
– volume: 148
  start-page: 163
  year: 2013
  end-page: 167
  ident: CR136
  article-title: Effect of omega-3 fatty acids for indicated prevention of young patients at risk for psychosis: when do they begin to be effective?
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2013.05.027
– volume: 18
  start-page: 466
  year: 2012
  end-page: 478
  ident: CR112
  article-title: Glutamate and psychosis risk
  publication-title: Curr Pharm Des
  doi: 10.2174/138161212799316244
– volume: 108
  start-page: 78
  year: 2009
  end-page: 84
  ident: CR182
  article-title: Regional dopamine synthesis in patients with schizophrenia using L-[beta-11C]DOPA PET
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2008.11.006
– volume: 72
  start-page: 1439
  year: 2011
  end-page: 1444
  ident: CR121
  article-title: An algorithm-based approach to first-episode schizophrenia: response rates over 3 prospective antipsychotic trials with a retrospective data analysis
  publication-title: J Clin Psychiatry
  doi: 10.4088/JCP.09m05785yel
– volume: 460
  start-page: 744
  year: 2009
  end-page: 747
  ident: CR87
  article-title: Common variants conferring risk of schizophrenia
  publication-title: Nature
  doi: 10.1038/nature08186
– volume: 15
  start-page: 174
  year: 2014
  end-page: 187
  ident: CR151
  article-title: Inflammatory cytokine network in schizophrenia
  publication-title: World J Biol Psychiatry
  doi: 10.3109/15622975.2013.830774
– volume: 66
  start-page: 533
  year: 2009
  end-page: 539
  ident: CR69
  article-title: OASIS. Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2009.05.006
– volume: 60
  start-page: 645
  year: 1988
  end-page: 663
  ident: CR108
  article-title: Sites of antagonist action on N-methyl-D- aspartic acid receptors studied using fluctuation analysis and a rapid perfusion technique
  publication-title: J Neurophysiol
  doi: 10.1152/jn.1988.60.2.645
– volume: 70
  start-page: 664
  year: 2013
  end-page: 665
  ident: CR109
  article-title: Nitric oxide and symptom reduction in schizophrenia
  publication-title: JAMA Psychiatry
  doi: 10.1001/jamapsychiatry.2013.210
– volume: 18
  start-page: 1580
  year: 2012
  end-page: 1592
  ident: CR44
  article-title: Genetic data supporting the NMDA glutamate receptor hypothesis for schizophrenia
  publication-title: Curr Pharm Des
  doi: 10.2174/138161212799958594
– volume: 126
  start-page: 414
  year: 1975
  end-page: 422
  ident: CR211
  article-title: The brain stem in psychosis
  publication-title: Br J Psychiatry
  doi: 10.1192/bjp.126.5.414
– volume: 21
  start-page: 4915
  year: 2001
  end-page: 4922
  ident: CR60
  article-title: Glutamatergic afferents from the hippocampus to the nucleus accumbens regulate activity of ventral tegmental area dopamine neurons
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.21-13-04915.2001
– volume: 22
  start-page: 597
  year: 1996
  end-page: 609
  ident: CR76
  article-title: An proton magnetic resonance spectroscopy study of schizophrenia patients
  publication-title: Schizophr Bull
  doi: 10.1093/schbul/22.4.597
– volume: 17
  start-page: 211
  year: 2011
  end-page: 216
  ident: CR138
  article-title: Efficacy of N-acetylcysteine in the treatment of nicotine dependence: a double-blind placebo-controlled pilot study
  publication-title: Eur Addict Res
  doi: 10.1159/000327682
– volume: 174
  start-page: 403
  year: 2006
  end-page: 412
  ident: CR146
  article-title: The effects of repetitive transcranial magnetic stimulation on cortical inhibition in healthy human subjects
  publication-title: Exp Brain Res
  doi: 10.1007/s00221-006-0472-0
– volume: 36
  start-page: 1781
  year: 2011
  end-page: 1791
  ident: CR66
  article-title: Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2011.65
– volume: 26
  start-page: 1273
  year: 2012
  end-page: 1279
  ident: CR208
  article-title: Different distribution patterns of lymphocytes and microglia in the hippocampus of patients with residual versus paranoid schizophrenia: further evidence for disease course-related immune alterations?
  publication-title: Brain Behav Immun
  doi: 10.1016/j.bbi.2012.08.005
– volume: 9
  start-page: 59
  year: 2008
  end-page: 63
  ident: CR201
  article-title: Frontolimbic glutamate alterations in first episode schizophrenia: evidence from a magnetic resonance spectroscopy study
  publication-title: World J Biol Psychiatry
  doi: 10.1080/15622970701227811
– volume: 371
  start-page: 1085
  year: 2008
  end-page: 1097
  ident: CR118
  article-title: Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(08)60486-9
– volume: 159
  start-page: 1944
  year: 2002
  end-page: 1946
  ident: CR202
  article-title: Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.159.11.1944
– volume: 92
  start-page: 108
  year: 2007
  end-page: 115
  ident: CR115
  article-title: Risperidone significantly inhibits interferon- gamma-induced microglial activation
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2007.01.019
– volume: 53
  start-page: 1075
  year: 2003
  end-page: 1085
  ident: CR23
  article-title: Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia
  publication-title: Biol Psychiatry
  doi: 10.1016/S0006-3223(03)00237-3
– volume: 117
  start-page: 83
  year: 2010
  end-page: 91
  ident: CR84
  article-title: GABA concentration in schizophrenia patients and the effects of antipsychotic medication: a proton magnetic resonance spectroscopy study
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2009.11.011
– volume: 21
  start-page: 861
  year: 2011
  end-page: 866
  ident: CR167
  article-title: Density of striatal D2 receptors in untreated first-episode psychosis: an I123-IBZM SPECT study
  publication-title: Eur Neuropsychopharmacol
  doi: 10.1016/j.euroneuro.2011.03.004
– volume: 47
  start-page: 59
  year: 2001
  end-page: 67
  ident: CR176
  article-title: Dopamine transporter density in young patients with schizophrenia assessed with [123]FP-CIT SPECT
  publication-title: Schizophr Res
  doi: 10.1016/S0920-9964(00)00023-2
– volume: 37
  start-page: 189
  year: 2011
  end-page: 198
  ident: CR70
  article-title: Prefrontal function at presentation directly related to clinical outcome in people at ultrahigh risk of psychosis
  publication-title: Schizophr Bull
  doi: 10.1093/schbul/sbp074
– volume: 170
  start-page: 609
  year: 2013
  end-page: 615
  ident: CR12
  article-title: Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.2013.12050674
– volume: 23
  start-page: 126
  year: 2013
  end-page: 132
  ident: CR156
  article-title: Striatal dopamine D2/3 receptor binding following dopamine depletion in subjects at Ultra High Risk for psychosis
  publication-title: Eur Neuropsychopharmacol
  doi: 10.1016/j.euroneuro.2012.04.015
– volume: 112
  start-page: 192
  year: 2009
  end-page: 193
  ident: CR82
  article-title: Reduction of brain gamma-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T Proton MRS study
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2009.04.026
– volume: 168
  start-page: 921
  year: 2011
  end-page: 929
  ident: CR57
  article-title: Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell type-specific features
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.2011.11010052
– volume: 68
  start-page: 128
  year: 2011
  end-page: 137
  ident: CR11
  article-title: Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archgenpsychiatry.2010.199
– volume: 70
  start-page: 663
  year: 2011
  end-page: 671
  ident: CR102
  article-title: Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2011.04.013
– volume: 58
  start-page: 13
  year: 2013
  end-page: 18
  ident: CR30
  article-title: Neuroimaging findings in the at-risk mental state: a review of recent literature
  publication-title: Can J Psychiatry
  doi: 10.1177/070674371305800104
– volume: 99
  start-page: 218
  year: 2008
  end-page: 224
  ident: CR195
  article-title: Elevated 3T proton MRS glutamate levels associated with poor Continuous Performance Test (CPT-0X) scores and genetic risk for schizophrenia
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2007.11.028
– volume: 129
  start-page: 169
  year: 2011
  end-page: 171
  ident: CR183
  article-title: Cannabis use and striatal D2 receptor density in untreated first-episode psychosis: an in vivo SPECT study
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2011.03.012
– volume: 46
  start-page: 681
  year: 1999
  end-page: 688
  ident: CR178
  article-title: Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(beta-11C) DOPA and PET
  publication-title: Biol Psychiatry
  doi: 10.1016/S0006-3223(99)00109-2
– volume: 271
  start-page: 126
  year: 1999
  end-page: 128
  ident: CR206
  article-title: Evidence for activation of microglia in patients with psychiatric illnesses
  publication-title: Neurosci. Lett
  doi: 10.1016/S0304-3940(99)00545-5
– volume: 17
  start-page: 319
  year: 1982
  end-page: 334
  ident: CR55
  article-title: Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence
  publication-title: J Psychiatr Res
  doi: 10.1016/0022-3956(82)90038-3
– volume: 39
  start-page: 120
  year: 2013
  end-page: 129
  ident: CR80
  article-title: Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies
  publication-title: Schizophr Bull
  doi: 10.1093/schbul/sbr069
– volume: 13
  start-page: 943
  year: 2010
  end-page: 950
  ident: CR98
  article-title: Peripheral benzodiazepine receptors in patients with chronic schizophrenia: a PET study with [11C]DAA1106
  publication-title: Int J Neuropsychopharmacol
  doi: 10.1017/S1461145710000313
– volume: 29
  start-page: 662
  year: 2006
  end-page: 666
  ident: CR166
  article-title: Striatal D2 receptor binding as a marker of prognosis and outcome in untreated first-episode psychosis
  publication-title: Neuroimage
  doi: 10.1016/j.neuroimage.2005.07.038
– year: 1992
  ident: CR3
  publication-title: Human Embryology & Teratology
– volume: 43
  start-page: 2301
  year: 2013
  end-page: 2309
  ident: CR22
  article-title: White-matter microstructure in previously drug-naive patients with schizophrenia after 6 weeks of treatment
  publication-title: Psychol Med
  doi: 10.1017/S0033291713000238
– volume: 66
  start-page: 89
  year: 2004
  end-page: 96
  ident: CR123
  article-title: Comparative effects of glycine and D-cycloserine on persistent negative symptoms in schizophrenia: a retrospective analysis
  publication-title: Schizophr Res
  doi: 10.1016/S0920-9964(03)00129-4
– volume: 63
  start-page: 9
  year: 2008
  end-page: 12
  ident: CR126
  article-title: Sarcosine (Nmethylglycine) treatment for acute schizophrenia: a randomized, double-blind study
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2007.04.038
– volume: 107
  start-page: 1225
  year: 2008
  end-page: 1235
  ident: CR117
  article-title: The antipsychotic spiperone attenuates inflammatory response in cultured microglia the reduction of proinflammatory cytokine expression and nitric oxide production
  publication-title: J Neurochem
  doi: 10.1111/j.1471-4159.2008.05675.x
– volume: 61
  start-page: 397
  year: 2012
  end-page: 406
  ident: CR5
  article-title: Imaging brain development: the adolescent brain
  publication-title: Neuroimage
  doi: 10.1016/j.neuroimage.2011.11.080
– volume: 132
  start-page: 1
  year: 2011
  end-page: 7
  ident: CR35
  article-title: Neurocognitive predictors of functional outcome two to 13 years after identification as ultra-high risk for psychosis
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2011.06.014
– volume: 124
  start-page: 1309
  year: 2013
  end-page: 1320
  ident: CR147
  article-title: Determining optimal rTMS parameters through changes in cortical inhibition
  publication-title: Clin Neurophysiol
  doi: 10.1016/j.clinph.2013.01.014
– volume: 28
  start-page: 13957
  year: 2008
  end-page: 13966
  ident: CR106
  article-title: Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.4457-08.2008
– volume: 147
  start-page: 24
  year: 2013
  end-page: 31
  ident: CR215
  article-title: Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in the postmortem frontal cortex from schizophrenia patients
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2013.02.017
– volume: 122
  start-page: 43
  year: 2010
  end-page: 52
  ident: CR177
  article-title: 18F-fallypride binding potential in patients with schizophrenia compared to healthy controls
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2010.03.043
– volume: 33
  start-page: 465
  year: 2008
  end-page: 472
  ident: CR125
  article-title: A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1301444
– volume: 168
  start-page: 1303
  year: 2011
  end-page: 1310
  ident: CR93
  article-title: Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.2011.11030516
– volume: 77
  start-page: 736
  year: 2013
  end-page: 749
  ident: CR50
  article-title: NMDA receptors subserve persistent neuronal firing during working memory in dorsolateral prefrontal cortex
  publication-title: Neuron
  doi: 10.1016/j.neuron.2012.12.032
– volume: 18
  start-page: 206
  year: 2013
  end-page: 214
  ident: CR210
  article-title: Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia
  publication-title: Mol Psychiatry
  doi: 10.1038/mp.2012.110
– volume: 40
  start-page: 181
  year: 2014
  end-page: 191
  ident: CR132
  article-title: Efficacy of Anti-inflammatory Agents to Improve Symptoms in Patients With Schizophrenia: An Update
  publication-title: Schizophr Bull
  doi: 10.1093/schbul/sbt139
– volume: 38
  start-page: 9
  year: 2012
  end-page: 14
  ident: CR61
  article-title: Is the acute NMDA receptor hypofunction a valid model of schizophrenia?
  publication-title: Schizophr Bull
  doi: 10.1093/schbul/sbr133
– volume: 204
  start-page: 322
  year: 2009
  end-page: 334
  ident: CR110
  article-title: Neural basis of psychosis-related behaviour in the infection model of schizophrenia
  publication-title: Behav Brain Res
  doi: 10.1016/j.bbr.2008.12.022
– volume: 42
  start-page: 157
  year: 2004
  end-page: 165
  ident: CR224
  article-title: Degeneration of microglial cells in frontal and temporal lobes of chronic schizophrenics
  publication-title: Folia Neuropathol
– volume: 31
  start-page: 11088
  year: 2011
  end-page: 11095
  ident: CR58
  article-title: Expression of GABA signaling molecules KCC2, NKCC1, and GAD1 in cortical development and schizophrenia
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.1234-11.2011
– volume: 55
  start-page: 126
  year: 2004
  end-page: 130
  ident: CR7
  article-title: Gray and white matter volume abnormalities in monozygotic and same-gender dizygotic twins discordant for schizophrenia
  publication-title: Biol Psychiatry
  doi: 10.1016/S0006-3223(03)00728-5
– volume: 156
  start-page: 544
  year: 1999
  end-page: 549
  ident: CR120
  article-title: Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder
  publication-title: Am J Psychiatry
  doi: 10.1176/ajp.156.10.1659
– volume: 40
  start-page: 120
  year: 2014
  end-page: 131
  ident: CR27
  article-title: Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: impact on psychopathology and transition to psychosis
  publication-title: Schizophr Bull
  doi: 10.1093/schbul/sbs136
– volume: 24
  start-page: 101
  year: 2014
  end-page: 110
  ident: CR32
  article-title: White matter alterations in early stages of schizophrenia: a systematic review of diffusion tensor imaging studies
  publication-title: J Neuroimaging
  doi: 10.1111/j.1552-6569.2012.00779.x
– volume: 1128
  start-page: 120
  year: 2007
  end-page: 129
  ident: CR148
  article-title: Facilitation of performance in a working memory task with rTMS stimulation of the precuneus: frequency- and time-dependent effects
  publication-title: Brain Res
  doi: 10.1016/j.brainres.2006.10.011
– volume: 161
  start-page: 1496
  year: 2004
  end-page: 1498
  ident: CR191
  article-title: Associated alterations of striatal dopamine D2/D3 receptor and transporter binding in drug-naive patients with schizophrenia: a dual-isotope SPECT study
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.161.8.1496
– volume: 64
  start-page: 40
  year: 2009
  end-page: 45
  ident: CR91
  article-title: MHC class I: an unexpected role in neuronal plasticity
  publication-title: Neuron
  doi: 10.1016/j.neuron.2009.09.044
– volume: 885
  start-page: 117
  year: 2000
  end-page: 121
  ident: CR223
  article-title: Expression of CD40 in the brain of Alzheimer's disease and other neurological diseases
  publication-title: Brain Res
  doi: 10.1016/S0006-8993(00)02984-X
– volume: 37
  start-page: 85
  year: 2014
  end-page: 94
  ident: CR41
  article-title: Dopaminergic basis of salience dysregulation in psychosis
  publication-title: Trends Neurosci
  doi: 10.1016/j.tins.2013.11.003
– volume: 105
  start-page: 16027
  year: 2008
  end-page: 16032
  ident: CR42
  article-title: Transient and selective overexpression of D2 receptors in the striatum causes persistent deficits in conditional associative learning
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0807746105
– volume: 7
  start-page: e29341
  year: 2012
  ident: CR133
  article-title: Glutathione precursor N-acetyl-cysteine modulates EEG synchronization in schizophrenia patients: a double-blind, randomized, placebo-controlled trial
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0029341
– ident: CR129
– volume: 112
  start-page: 305
  year: 2006
  end-page: 316
  ident: CR218
  article-title: Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-006-0090-8
– volume: 74
  start-page: 106
  year: 2013
  end-page: 112
  ident: CR157
  article-title: Presynaptic striatal dopamine dysfunction in people at ultra-high risk for psychosis: findings in a second cohort
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2012.11.017
– volume: 162
  start-page: 394
  year: 2005
  end-page: 396
  ident: CR63
  article-title: Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.162.2.394
– volume: 68
  start-page: 489
  year: 2011
  end-page: 495
  ident: CR31
  article-title: Neuroanatomical abnormalities that predate the onset of psychosis: a multicenter study
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archgenpsychiatry.2011.42
– volume: 161
  start-page: 1116
  year: 2004
  end-page: 1118
  ident: CR64
  article-title: 3-T proton MRS investigation of glutamate and glutamine in adolescents at high genetic risk for schizophrenia
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.161.6.1116
– volume: 60
  start-page: 621
  year: 2006
  end-page: 629
  ident: CR168
  article-title: Frontal Dopamine D2/3 Receptor Binding in Drug-Naive First-Episode Schizophrenic Patients Correlates with Positive Psychotic Symptoms and Gender
  publication-title: Biological Psychiatry
  doi: 10.1016/j.biopsych.2006.01.010
– volume: 23
  start-page: 245
  year: 2008
  end-page: 254
  ident: CR19
  article-title: Schizophrenia as a progressive brain disease
  publication-title: Eur Psychiatry
  doi: 10.1016/j.eurpsy.2007.10.013
– volume: 35
  start-page: 41
  year: 1999
  end-page: 50
  ident: CR172
  article-title: Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia
  publication-title: Schizophr Res
  doi: 10.1016/S0920-9964(98)00113-3
– volume: 24
  start-page: 697
  year: 1988
  end-page: 700
  ident: CR221
  article-title: Quantitative study of gliosis in schizophrenia and Huntington’s chorea
  publication-title: Biol Psychiatry
  doi: 10.1016/0006-3223(88)90144-8
– volume: 143
  start-page: 198
  year: 2013
  end-page: 202
  ident: CR153
  article-title: C-reactive protein is elevated in schizophrenia
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2012.10.041
– volume: 290
  start-page: R1345
  year: 2006
  end-page: R1356
  ident: CR51
  article-title: Prenatal exposure to interleukin-6 results in inflammatory neurodegeneration in hippocampus with NMDA/GABA(A) dysregulation and impaired spatial learning
  publication-title: Am J Physiol Regul Integr Comp Physiol
  doi: 10.1152/ajpregu.00268.2005
– volume: 6
  start-page: 361
  year: 2003
  end-page: 370
  ident: CR189
  article-title: Decreased thalamic D2/D3 receptor binding in drug-naive patients with schizophrenia: a PET study with [11C]FLB 457
  publication-title: Int. J Neuropsychopharmacol
  doi: 10.1017/S1461145703003699
– volume: 20
  start-page: 285
  year: 1990
  end-page: 304
  ident: CR207
  article-title: Schizophrenia and the brain: a prospective clinico-neuropathological study
  publication-title: Psychol Med
  doi: 10.1017/S0033291700017608
– volume: 43
  start-page: 81
  year: 2005
  end-page: 89
  ident: CR225
  article-title: Quantitative analysis of activated microglia, ramified and damage of processes in the frontal and temporal lobes of chronic schizophrenics
  publication-title: Folia Neuropathol
– volume: 63
  start-page: 801
  year: 2008
  end-page: 808
  ident: CR150
  article-title: Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2007.09.024
– volume: 6
  start-page: 312
  year: 2005
  end-page: 324
  ident: CR56
  article-title: Cortical inhibitory neurons and schizophrenia
  publication-title: Nat Rev Neurosci
  doi: 10.1038/nrn1648
– volume: 22
  start-page: 3708
  year: 2002
  end-page: 3719
  ident: CR163
  article-title: Prefrontal dopamine D1 receptors and working memory in schizophrenia
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.22-09-03708.2002
– ident: CR72
– volume: 25
  start-page: 859
  year: 2011
  end-page: 885
  ident: CR122
  article-title: Meta-analysis of the efficacy of adjunctive NMDA receptor modulators in chronic schizophrenia
  publication-title: CNS Drugs
  doi: 10.2165/11586650-000000000-00000
– volume: 34
  start-page: 2353
  year: 2013
  end-page: 2365
  ident: CR13
  article-title: Altered white matter connectivity in never-medicated patients with schizophrenia
  publication-title: Hum Brain Mapp
  doi: 10.1002/hbm.22075
– volume: 39
  start-page: 1096
  year: 2013
  end-page: 1104
  ident: CR62
  article-title: measurements of glutamate, GABA, and NAAG in schizophrenia
  publication-title: Schizophr Bull
  doi: 10.1093/schbul/sbs092
– volume: 189
  start-page: 381
  year: 2006
  end-page: 382
  ident: CR8
  article-title: Brain volume changes in the first year of illness and 5-year outcome of schizophrenia
  publication-title: Br J Psychiatry
  doi: 10.1192/bjp.bp.105.015701
– volume: 70
  start-page: 1107
  year: 2013
  end-page: 1112
  ident: CR1
  article-title: Schizophrenia is a cognitive illness: time for a change in focus
  publication-title: JAMA Psychiatry
  doi: 10.1001/jamapsychiatry.2013.155
– volume: 55
  start-page: 225
  year: 1998
  end-page: 232
  ident: CR205
  article-title: Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia
  publication-title: Arch. Gen. Psychiatry
  doi: 10.1001/archpsyc.55.3.225
– volume: 42
  start-page: 151
  year: 2008
  end-page: 157
  ident: CR220
  article-title: Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide
  publication-title: J Psychiatr Res
  doi: 10.1016/j.jpsychires.2006.10.013
– volume: 104
  start-page: 1361
  year: 1997
  end-page: 1370
  ident: CR212
  article-title: Decreases in peripheral-type benzodiazepine receptors in postmortem brains of chronic schizophrenics
  publication-title: J Neural Transm
  doi: 10.1007/BF01294737
– volume: 65
  start-page: 39
  year: 2003
  end-page: 46
  ident: CR173
  article-title: Dopamine transporter change in drug-naive schizophrenia: an imaging study with 99mTc-TRODAT-1
  publication-title: Schizophr Res
  doi: 10.1016/S0920-9964(03)00006-9
– volume: 157
  start-page: 269
  year: 2000
  end-page: 271
  ident: CR175
  article-title: Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.157.2.269
– volume: 101
  start-page: 133
  year: 2008
  end-page: 141
  ident: CR186
  article-title: Dual-isotope SPECT imaging of striatal dopamine: first episode, drug naïve schizophrenic patients
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2007.11.010
– volume: 41
  start-page: 625
  year: 2007
  end-page: 634
  ident: CR200
  article-title: Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study
  publication-title: J Psychiatr Res
  doi: 10.1016/j.jpsychires.2006.07.002
– volume: 39
  start-page: 1131
  year: 1982
  end-page: 1139
  ident: CR85
  article-title: Neuropathology of schizophrenia
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.1982.04290100011003
– volume: 61
  start-page: 1218
  year: 2007
  end-page: 1219
  ident: CR74
  article-title: Regarding "Increased prefrontal and hippocampal glutamate concentration in schizophrenia: evidence from a magnetic resonance spectroscopy study”
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2006.05.037
– volume: 32
  start-page: 17365
  year: 2012
  end-page: 17372
  ident: CR111
  article-title: Excessive extracellular volume reveals a neurodegenerative pattern in schizophrenia onset
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.2904-12.2012
– volume: 8
  start-page: 251
  year: 1983
  end-page: 260
  ident: CR213
  article-title: A histological study of the corpus callosum in chronic schizophrenia
  publication-title: Psychiatry Res
  doi: 10.1016/0165-1781(83)90013-6
– volume: 71
  start-page: 676
  year: 2004
  end-page: 683
  ident: CR54
  article-title: Regulation of N-methyl-D- aspartate receptor subunit expression in the fetal guinea pig brain
  publication-title: Biol Reprod
  doi: 10.1095/biolreprod.104.027946
– volume: 18
  start-page: 133
  year: 2013
  ident: CR114
  article-title: Markers of inflammation in the prefrontal cortex of individuals with schizophrenia
  publication-title: Mol Psychiatry
  doi: 10.1038/mp.2012.199
– volume: 7
  start-page: 31
  year: 2013
  ident: CR46
  article-title: NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia
  publication-title: Front Cell Neurosci
  doi: 10.3389/fncel.2013.00031
– volume: 30
  start-page: 3777
  year: 2010
  end-page: 3781
  ident: CR83
  article-title: GABA concentration is reduced in visual cortex in schizophrenia and correlates with orientation-specific surround suppression
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.6158-09.2010
– volume: 3
  start-page: 320
  year: 2012
  end-page: 327
  ident: CR92
  article-title: Prenatal infection, maternal immune activation, and risk for schizophrenia
  publication-title: Transl Neurosci
  doi: 10.2478/s13380-012-0045-6
– volume: 36
  start-page: 2325
  year: 2012
  end-page: 2333
  ident: CR16
  article-title: Multimodal meta-analysis of structural and functional brain changes in first episode psychosis and the effects of antipsychotic medication
  publication-title: Neurosci Biobehav Rev
  doi: 10.1016/j.neubiorev.2012.07.012
– volume: 19
  start-page: 1217
  year: 2010
  end-page: 1233
  ident: CR130
  article-title: The inhibitory GABA system as a therapeutic target for cognitive symptoms in schizophrenia: investigational agents in the pipeline
  publication-title: Expert Opin Investig Drugs
  doi: 10.1517/13543784.2010.513382
– volume: 20
  start-page: 1004
  year: 2012
  end-page: 1008
  ident: CR86
  article-title: PGC Schizophrenia (GWAS)Consortium. Expression QTL analysis of top loci from GWAS meta-analysis highlights additional schizophrenia candidate genes
  publication-title: Eur J Hum Genet
  doi: 10.1038/ejhg.2012.38
– volume: 71
  start-page: 265
  year: 2014
  end-page: 272
  ident: CR81
  article-title: Increased glutamine in patients undergoing long-term treatment for schizophrenia: a proton magnetic resonance spectroscopy study at 3 T
  publication-title: JAMA Psychiatry
  doi: 10.1001/jamapsychiatry.2013.3939
– volume: 15
  start-page: CR82
  year: 2009
  end-page: CR88
  ident: CR78
  article-title: Duration of untreated psychosis and proton magnetic resonance spectroscopy (1H-MRS) findings in first-episode schizophrenia
  publication-title: Med Sci Monit
– volume: 2
  start-page: e190
  year: 2012
  ident: CR17
  article-title: Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies
  publication-title: Transl Psychiatry
  doi: 10.1038/tp.2012.116
– volume: 506
  start-page: 179
  year: 2014
  end-page: 184
  ident: CR49
  article-title: mutations in schizophrenia implicate synaptic networks
  publication-title: Nature
  doi: 10.1038/nature12929
– volume: 64
  start-page: 820
  year: 2008
  end-page: 822
  ident: CR96
  article-title: Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2008.04.025
– volume: 39
  start-page: 1129
  year: 2013
  end-page: 1138
  ident: CR2
  article-title: Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects
  publication-title: Schizophr Bull
  doi: 10.1093/schbul/sbs118
– volume: 68
  start-page: 199
  year: 2013
  end-page: 220
  ident: CR39
  article-title: The enduring centrality of dopamine in the pathophysiology of schizophrenia: evidence from the prodrome to the first psychotic episode
  publication-title: Adv Pharmacol
  doi: 10.1016/B978-0-12-411512-5.00010-5
– volume: 468
  start-page: 187
  year: 2010
  end-page: 193
  ident: CR131
  article-title: Rethinking schizophrenia
  publication-title: Nature
  doi: 10.1038/nature09552
– volume: 16
  start-page: 885
  year: 2011
  end-page: 886
  ident: CR161
  article-title: Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study
  publication-title: Mol Psychiatry
  doi: 10.1038/mp.2011.20
– volume: 54
  start-page: 959
  year: 1997
  end-page: 965
  ident: CR73
  article-title: Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.1997.01830220085012
– volume: 109
  start-page: 16720
  year: 2012
  end-page: 16725
  ident: CR43
  article-title: NMDA receptor function in large-scale anticorrelated neural systems with implications for cognition and schizophrenia
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1208494109
– volume: 66
  start-page: 13
  year: 2009
  end-page: 20
  ident: CR37
  article-title: Elevated striatal dopamine function linked to prodromal signs of schizophrenia
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archgenpsychiatry.2008.514
– volume: 68
  start-page: 871
  year: 2011
  end-page: 880
  ident: CR10
  article-title: Changes in cortical thickness during the course of illness in schizophrenia
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archgenpsychiatry.2011.88
– volume: 34
  start-page: 354
  year: 2008
  end-page: 366
  ident: CR6
  article-title: What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia
  publication-title: Schizophr Bull
  doi: 10.1093/schbul/sbm168
– volume: 23
  start-page: 675
  year: 2013
  end-page: 685
  ident: CR144
  article-title: Exercise therapy, cardiorespiratory fitness and their effect on brain volumes: a randomised controlled trial in patients with schizophrenia and healthy controls
  publication-title: Eur Neuropsychopharmacol
  doi: 10.1016/j.euroneuro.2012.08.008
– volume: 173
  start-page: 183
  year: 2009
  end-page: 189
  ident: CR187
  article-title: Increase of striatal dopamine transmission in first episode drug-naive schizophrenic patients as demonstrated by [(123)I]IBZM SPECT
  publication-title: Psychiatry Res
  doi: 10.1016/j.pscychresns.2008.11.001
– volume: 38
  start-page: 72
  year: 2014
  end-page: 93
  ident: CR103
  article-title: Inflammation and the two-hit hypothesis of schizophrenia
  publication-title: Neurosci Biobehav Rev
  doi: 10.1016/j.neubiorev.2013.11.006
– volume: 34
  start-page: 1078
  year: 2009
  end-page: 1086
  ident: CR170
  article-title: The dopamine D2 receptors in high-affinity state and D3 receptors in schizophrenia: a clinical [11C]-(+)-PHNO PET study
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2008.199
– volume: 50
  start-page: 1801
  year: 2009
  end-page: 1807
  ident: CR97
  article-title: Neuroinflammation in schizophrenia-related psychosis: a PET study
  publication-title: J Nucl Med
  doi: 10.2967/jnumed.109.066647
– volume: 290
  start-page: 2155
  year: 2000
  end-page: 2159
  ident: CR90
  article-title: Functional requirement for class I MHC in CNS development and plasticity
  publication-title: Science
  doi: 10.1126/science.290.5499.2155
– volume: 67
  start-page: 683
  year: 2010
  end-page: 691
  ident: CR158
  article-title: Abnormal frontostriatal interactions in people with prodromal signs of psychosis: a multimodal imaging study
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archgenpsychiatry.2010.77
– ident: CR181
– volume: 149
  start-page: 112
  year: 2013
  end-page: 115
  ident: CR143
  article-title: Effects of aerobic interval training on metabolic complications and cardiorespiratory fitness in young adults with psychotic disorders: a pilot study
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2013.06.040
– volume: 181
  start-page: 401
  year: 2005
  end-page: 406
  ident: CR179
  article-title: Decreased striatal dopamine transporter binding assessed with [123I] FP-CIT in first-episode schizophrenic patients with and without short-term antipsychotic-induced parkinsonism
  publication-title: Psychopharmacology (Berl)
  doi: 10.1007/s00213-005-2250-2
– volume: 148
  start-page: 165
  year: 2006
  end-page: 173
  ident: CR190
  article-title: Dopamine D2 receptor binding in drug-naïve patients with schizophrenia examined with raclopride-C11 and positron emission tomography
  publication-title: Psychiatry Res
  doi: 10.1016/j.pscychresns.2006.05.009
– volume: 26
  start-page: 794
  year: 2012
  end-page: 805
  ident: CR164
  article-title: Increased prefrontal cortical D receptors in drug naive patients with schizophrenia: a PET study with [ C]NNC112
  publication-title: J Psychopharmacol (Oxford)
  doi: 10.1177/0269881111409265
– volume: 263
  start-page: 367
  year: 2013
  end-page: 377
  ident: CR124
  article-title: Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders
  publication-title: Eur Arch Psychiatry Clin Neurosci
  doi: 10.1007/s00406-013-0399-y
– volume: 191
  start-page: 325
  year: 2007
  end-page: 334
  ident: CR203
  article-title: Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia
  publication-title: Br J Psychiatry
  doi: 10.1192/bjp.bp.106.033670
– volume: 93
  start-page: 261
  year: 2007
  end-page: 265
  ident: CR152
  article-title: C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2007.03.022
– volume: 38
  start-page: 98
  year: 2013
  end-page: 106
  ident: CR162
  article-title: Dopamine D2 and D3 binding in people at clinical high risk for schizophrenia, antipsychotic-naive patients and healthy controls while performing a cognitive task
  publication-title: J Psychiatry Neurosci
  doi: 10.1503/jpn.110181
– volume: 70
  start-page: 1057
  year: 2013
  end-page: 1066
  ident: CR198
  article-title: Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance spectroscopy study
  publication-title: JAMA Psychiatry
  doi: 10.1001/jamapsychiatry.2013.289
– volume: 127
  start-page: 464
  year: 2013
  end-page: 473
  ident: CR140
  article-title: Exercise therapy improves mental and physical health in schizophrenia: a randomised controlled trial
  publication-title: Acta Psychiatr Scand
  doi: 10.1111/acps.12029
– volume: 34
  start-page: 354
  year: 2008
  end-page: 366
  ident: CR20
  article-title: What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia
  publication-title: Schizophr Bull.
  doi: 10.1093/schbul/sbm168
– volume: 346
  start-page: 1130
  year: 1995
  end-page: 1131
  ident: CR171
  article-title: Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients
  publication-title: Lancet
  doi: 10.1016/S0140-6736(95)91801-9
– volume: 25
  start-page: 159
  year: 2006
  end-page: 165
  ident: CR180
  article-title: Striatal dopamine transporter density decrease in first episode schizophrenic patients treated with risperidone
  publication-title: Rev Esp Med Nucl
  doi: 10.1157/13088411
– volume: 68
  start-page: 881
  year: 2011
  end-page: 890
  ident: CR194
  article-title: Thalamic glutamate levels as a predictor of cortical response during executive functioning in subjects at high risk for psychosis
  publication-title: Arch. Gen. Psychiatry
  doi: 10.1001/archgenpsychiatry.2011.46
– volume: 169
  start-page: 1203
  year: 2012
  end-page: 1210
  ident: CR113
  article-title: Dopamine synthesis capacity in patients with treatment-resistant schizophrenia
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.2012.12010144
– volume: 85
  start-page: 232
  year: 2006
  end-page: 244
  ident: CR165
  article-title: D2/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2006.03.042
– volume: 21
  start-page: 1043
  year: 1986
  end-page: 1050
  ident: CR216
  article-title: Gliosis in schizophrenia: a survey
  publication-title: Biol Psychiatry
  doi: 10.1016/0006-3223(86)90285-4
– volume: 26
  start-page: 8
  year: 2012
  end-page: 14
  ident: CR18
  article-title: The course of brain abnormalities in schizophrenia: can we slow the progression?
  publication-title: J Psychopharmacol
  doi: 10.1177/0269881111408964
– volume: 10
  start-page: 13
  year: 2012
  end-page: 24
  ident: CR15
  article-title: Diffusion tensor imaging findings of white matter changes in first episode schizophrenia: a systematic review
  publication-title: Clin Psychopharmacol Neurosci
  doi: 10.9758/cpn.2012.10.1.13
– volume: 102
  start-page: 163
  year: 2008
  end-page: 170
  ident: CR204
  article-title: A 1H-MRS investigation of the medial temporal lobe in antipsychotic-naïve and early-treated first episode psychosis
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2008.03.012
– volume: 262
  start-page: 183
  year: 2012
  end-page: 191
  ident: CR188
  article-title: Dual-isotope SPECT imaging of striatal dopamine: a comparative study between never-treated and haloperidol-treated first-episode schizophrenic patients
  publication-title: Eur Arch Psychiatry Clin Neurosci
  doi: 10.1007/s00406-011-0269-4
– volume: 67
  start-page: 146
  year: 2010
  end-page: 154
  ident: CR135
  article-title: Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archgenpsychiatry.2009.192
– volume: 66
  start-page: 606
  year: 2009
  end-page: 615
  ident: CR169
  article-title: The effect of antipsychotics on the high-affinity state of D2 and D3 receptors: a positron emission tomography study With [11C]-(+)-PHNO
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archgenpsychiatry.2009.43
– volume: 69
  start-page: 97
  year: 2011
  end-page: 99
  ident: CR196
  article-title: Altered medial temporal activation related to local glutamate levels in subjects with prodromal signs of psychosis
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2010.08.033
– volume: 67
  start-page: 133
  year: 2010
  end-page: 143
  ident: CR145
  article-title: Hippocampal plasticity in response to exercise in schizophrenia
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archgenpsychiatry.2009.193
– volume: 256
  start-page: 115
  year: 2006
  end-page: 121
  ident: CR185
  article-title: Striatal dopamine transporter availability is associated with the productive psychotic state in first episode, drug-naive schizophrenic patients
  publication-title: Eur Arch Psychiatry Clin Neurosci
  doi: 10.1007/s00406-005-0618-2
– volume: 8
  start-page: 251
  year: 1983
  ident: BFmp201466_CR213
  publication-title: Psychiatry Res
  doi: 10.1016/0165-1781(83)90013-6
– volume: 39
  start-page: 1129
  year: 2013
  ident: BFmp201466_CR2
  publication-title: Schizophr Bull
  doi: 10.1093/schbul/sbs118
– volume: 156
  start-page: 544
  year: 1999
  ident: BFmp201466_CR120
  publication-title: Am J Psychiatry
  doi: 10.1176/ajp.156.10.1659
– volume: 26
  start-page: 794
  year: 2012
  ident: BFmp201466_CR164
  publication-title: J Psychopharmacol (Oxford)
  doi: 10.1177/0269881111409265
– volume: 117
  start-page: 395
  year: 2009
  ident: BFmp201466_CR24
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-008-0430-y
– volume: 59
  start-page: 137
  year: 2000
  ident: BFmp201466_CR214
  publication-title: J Neuropathol Exp Neurol
  doi: 10.1093/jnen/59.2.137
– volume: 159
  start-page: 1944
  year: 2002
  ident: BFmp201466_CR202
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.159.11.1944
– volume: 22
  start-page: 597
  year: 1996
  ident: BFmp201466_CR76
  publication-title: Schizophr Bull
  doi: 10.1093/schbul/22.4.597
– volume: 256
  start-page: 115
  year: 2006
  ident: BFmp201466_CR185
  publication-title: Eur Arch Psychiatry Clin Neurosci
  doi: 10.1007/s00406-005-0618-2
– volume: 271
  start-page: 126
  year: 1999
  ident: BFmp201466_CR206
  publication-title: Neurosci. Lett
  doi: 10.1016/S0304-3940(99)00545-5
– volume-title: Human Embryology & Teratology
  year: 1992
  ident: BFmp201466_CR3
– volume: 21
  start-page: 4915
  year: 2001
  ident: BFmp201466_CR60
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.21-13-04915.2001
– volume: 39
  start-page: 1131
  year: 1982
  ident: BFmp201466_CR85
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.1982.04290100011003
– volume: 72
  start-page: 1439
  year: 2011
  ident: BFmp201466_CR121
  publication-title: J Clin Psychiatry
  doi: 10.4088/JCP.09m05785yel
– volume: 32
  start-page: 17365
  year: 2012
  ident: BFmp201466_CR111
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.2904-12.2012
– volume: 142
  start-page: 108
  year: 2012
  ident: BFmp201466_CR28
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2012.09.004
– volume: 71
  start-page: 444
  year: 2012
  ident: BFmp201466_CR95
  publication-title: Ann Neurol.
  doi: 10.1002/ana.22620
– volume: 63
  start-page: 801
  year: 2008
  ident: BFmp201466_CR150
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2007.09.024
– volume: 290
  start-page: R1345
  year: 2006
  ident: BFmp201466_CR51
  publication-title: Am J Physiol Regul Integr Comp Physiol
  doi: 10.1152/ajpregu.00268.2005
– volume: 162
  start-page: 394
  year: 2005
  ident: BFmp201466_CR63
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.162.2.394
– volume: 1128
  start-page: 120
  year: 2007
  ident: BFmp201466_CR148
  publication-title: Brain Res
  doi: 10.1016/j.brainres.2006.10.011
– volume: 6
  start-page: 312
  year: 2005
  ident: BFmp201466_CR56
  publication-title: Nat Rev Neurosci
  doi: 10.1038/nrn1648
– volume: 17
  start-page: 319
  year: 1982
  ident: BFmp201466_CR55
  publication-title: J Psychiatr Res
  doi: 10.1016/0022-3956(82)90038-3
– volume: 75
  start-page: 262
  year: 2014
  ident: BFmp201466_CR89
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2013.10.003
– volume: 27
  start-page: 10695
  year: 2007
  ident: BFmp201466_CR105
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.2178-07.2007
– volume: 33
  start-page: 2187
  year: 2008
  ident: BFmp201466_CR134
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1301624
– volume: 23
  start-page: 245
  year: 2008
  ident: BFmp201466_CR19
  publication-title: Eur Psychiatry
  doi: 10.1016/j.eurpsy.2007.10.013
– volume: 161
  start-page: 1016
  year: 2004
  ident: BFmp201466_CR192
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.161.6.1016
– volume: 9
  start-page: 59
  year: 2008
  ident: BFmp201466_CR201
  publication-title: World J Biol Psychiatry
  doi: 10.1080/15622970701227811
– volume: 6
  start-page: 361
  year: 2003
  ident: BFmp201466_CR189
  publication-title: Int. J Neuropsychopharmacol
  doi: 10.1017/S1461145703003699
– volume: 63
  start-page: 257
  year: 2009
  ident: BFmp201466_CR100
  publication-title: Psychiatry Clin Neurosci
  doi: 10.1111/j.1440-1819.2009.01945.x
– volume: 18
  start-page: 206
  year: 2013
  ident: BFmp201466_CR210
  publication-title: Mol Psychiatry
  doi: 10.1038/mp.2012.110
– volume: 53
  start-page: 1075
  year: 2003
  ident: BFmp201466_CR23
  publication-title: Biol Psychiatry
  doi: 10.1016/S0006-3223(03)00237-3
– volume: 189
  start-page: 381
  year: 2006
  ident: BFmp201466_CR8
  publication-title: Br J Psychiatry
  doi: 10.1192/bjp.bp.105.015701
– volume: 24
  start-page: 727
  year: 1988
  ident: BFmp201466_CR222
  publication-title: Biol Psychiatry
  doi: 10.1016/0006-3223(88)90154-0
– volume: 18
  start-page: 1580
  year: 2012
  ident: BFmp201466_CR44
  publication-title: Curr Pharm Des
  doi: 10.2174/138161212799958594
– volume: 38
  start-page: 98
  year: 2013
  ident: BFmp201466_CR162
  publication-title: J Psychiatry Neurosci
  doi: 10.1503/jpn.110181
– volume: 43
  start-page: 81
  year: 2005
  ident: BFmp201466_CR225
  publication-title: Folia Neuropathol
– volume: 159
  start-page: 761
  year: 2002
  ident: BFmp201466_CR174
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.159.5.761
– volume: 30
  start-page: 3777
  year: 2010
  ident: BFmp201466_CR83
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.6158-09.2010
– volume: 15
  start-page: CR82
  year: 2009
  ident: BFmp201466_CR78
  publication-title: Med Sci Monit
– volume: 170
  start-page: 609
  year: 2013
  ident: BFmp201466_CR12
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.2013.12050674
– volume: 67
  start-page: 683
  year: 2010
  ident: BFmp201466_CR158
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archgenpsychiatry.2010.77
– ident: BFmp201466_CR72
  doi: 10.1093/schbul/sbt124
– volume: 37
  start-page: 2418
  year: 2013
  ident: BFmp201466_CR9
  publication-title: Neurosci Biobehav Rev
  doi: 10.1016/j.neubiorev.2012.09.006
– volume: 60
  start-page: 645
  year: 1988
  ident: BFmp201466_CR108
  publication-title: J Neurophysiol
  doi: 10.1152/jn.1988.60.2.645
– volume: 31
  start-page: 349
  year: 2011
  ident: BFmp201466_CR128
  publication-title: J Clin Psychopharmacol
  doi: 10.1097/JCP.0b013e318218dcd5
– volume: 64
  start-page: 820
  year: 2008
  ident: BFmp201466_CR96
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2008.04.025
– volume: 16
  start-page: 885
  year: 2011
  ident: BFmp201466_CR161
  publication-title: Mol Psychiatry
  doi: 10.1038/mp.2011.20
– volume: 54
  start-page: 138
  year: 2004
  ident: BFmp201466_CR52
  publication-title: Synapse
  doi: 10.1002/syn.20073
– volume: 64
  start-page: 40
  year: 2009
  ident: BFmp201466_CR91
  publication-title: Neuron
  doi: 10.1016/j.neuron.2009.09.044
– volume: 34
  start-page: 167
  year: 2013
  ident: BFmp201466_CR137
  publication-title: Trends Pharmacol Sci
  doi: 10.1016/j.tips.2013.01.001
– volume: 75
  start-page: 276
  year: 2014
  ident: BFmp201466_CR88
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2013.09.018
– volume: 117
  start-page: 83
  year: 2010
  ident: BFmp201466_CR84
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2009.11.011
– volume: 19
  start-page: 488
  year: 2005
  ident: BFmp201466_CR184
  publication-title: J Psychopharmacol (Oxford)
  doi: 10.1177/0269881105056530
– volume: 54
  start-page: 959
  year: 1997
  ident: BFmp201466_CR73
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.1997.01830220085012
– volume: 157
  start-page: 269
  year: 2000
  ident: BFmp201466_CR175
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.157.2.269
– volume: 371
  start-page: 1085
  year: 2008
  ident: BFmp201466_CR118
  publication-title: Lancet
  doi: 10.1016/S0140-6736(08)60486-9
– volume: 111
  start-page: 86
  year: 2009
  ident: BFmp201466_CR71
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2009.03.036
– volume: 70
  start-page: 1107
  year: 2013
  ident: BFmp201466_CR1
  publication-title: JAMA Psychiatry
  doi: 10.1001/jamapsychiatry.2013.155
– volume: 105
  start-page: 16027
  year: 2008
  ident: BFmp201466_CR42
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0807746105
– volume: 73
  start-page: 153
  year: 2005
  ident: BFmp201466_CR199
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2004.08.021
– volume: 143
  start-page: 198
  year: 2013
  ident: BFmp201466_CR153
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2012.10.041
– volume: 85
  start-page: 232
  year: 2006
  ident: BFmp201466_CR165
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2006.03.042
– volume: 55
  start-page: 225
  year: 1998
  ident: BFmp201466_CR205
  publication-title: Arch. Gen. Psychiatry
  doi: 10.1001/archpsyc.55.3.225
– volume: 24
  start-page: 697
  year: 1988
  ident: BFmp201466_CR221
  publication-title: Biol Psychiatry
  doi: 10.1016/0006-3223(88)90144-8
– volume: 68
  start-page: 871
  year: 2011
  ident: BFmp201466_CR10
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archgenpsychiatry.2011.88
– volume: 71
  start-page: 676
  year: 2004
  ident: BFmp201466_CR54
  publication-title: Biol Reprod
  doi: 10.1095/biolreprod.104.027946
– volume: 11
  start-page: 565
  year: 2011
  ident: BFmp201466_CR116
  publication-title: Mini Rev Med Chem
  doi: 10.2174/138955711795906941
– volume: 70
  start-page: e1
  year: 2011
  ident: BFmp201466_CR193
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2010.11.030
– volume: 45
  start-page: 1403
  year: 1999
  ident: BFmp201466_CR197
  publication-title: Biol Psychiatry
  doi: 10.1016/S0006-3223(99)00007-4
– volume: 40
  start-page: 120
  year: 2014
  ident: BFmp201466_CR27
  publication-title: Schizophr Bull
  doi: 10.1093/schbul/sbs136
– volume: 181
  start-page: 401
  year: 2005
  ident: BFmp201466_CR179
  publication-title: Psychopharmacology (Berl)
  doi: 10.1007/s00213-005-2250-2
– volume: 15
  start-page: 629
  year: 2010
  ident: BFmp201466_CR75
  publication-title: Mol Psychiatry.
  doi: 10.1038/mp.2009.121
– volume: 74
  start-page: 106
  year: 2013
  ident: BFmp201466_CR157
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2012.11.017
– volume: 42
  start-page: 868
  year: 2008
  ident: BFmp201466_CR219
  publication-title: J Psychiatr Res
  doi: 10.1016/j.jpsychires.2007.10.001
– volume: 46
  start-page: 681
  year: 1999
  ident: BFmp201466_CR178
  publication-title: Biol Psychiatry
  doi: 10.1016/S0006-3223(99)00109-2
– volume: 47
  start-page: 59
  year: 2001
  ident: BFmp201466_CR176
  publication-title: Schizophr Res
  doi: 10.1016/S0920-9964(00)00023-2
– volume: 112
  start-page: 305
  year: 2006
  ident: BFmp201466_CR218
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-006-0090-8
– volume: 15
  start-page: 174
  year: 2014
  ident: BFmp201466_CR151
  publication-title: World J Biol Psychiatry
  doi: 10.3109/15622975.2013.830774
– volume: 16
  start-page: 67
  year: 2011
  ident: BFmp201466_CR159
  publication-title: Mol. Psychiatry
  doi: 10.1038/mp.2009.108
– volume: 7
  start-page: e29341
  year: 2012
  ident: BFmp201466_CR133
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0029341
– volume: 34
  start-page: 1078
  year: 2009
  ident: BFmp201466_CR170
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2008.199
– volume: 34
  start-page: 2353
  year: 2013
  ident: BFmp201466_CR13
  publication-title: Hum Brain Mapp
  doi: 10.1002/hbm.22075
– volume: 209
  start-page: 266
  year: 2013
  ident: BFmp201466_CR29
  publication-title: Psychiatry Res
  doi: 10.1016/j.psychres.2013.03.004
– volume: 132
  start-page: 1
  year: 2011
  ident: BFmp201466_CR35
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2011.06.014
– volume: 10
  start-page: 40
  year: 2005
  ident: BFmp201466_CR47
  publication-title: Mol Psychiatry
  doi: 10.1038/sj.mp.4001558
– volume: 67
  start-page: 320
  year: 2013
  ident: BFmp201466_CR154
  publication-title: Nord J Psychiatry
  doi: 10.3109/08039488.2012.745601
– volume: 188
  start-page: 510
  year: 2006
  ident: BFmp201466_CR21
  publication-title: Br J Psychiatry
  doi: 10.1192/bjp.188.6.510
– volume: 62
  start-page: 371
  year: 2005
  ident: BFmp201466_CR160
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.62.4.371
– volume: 58
  start-page: 13
  year: 2013
  ident: BFmp201466_CR30
  publication-title: Can J Psychiatry
  doi: 10.1177/070674371305800104
– volume: 127
  start-page: 464
  year: 2013
  ident: BFmp201466_CR140
  publication-title: Acta Psychiatr Scand
  doi: 10.1111/acps.12029
– volume: 147
  start-page: 24
  year: 2013
  ident: BFmp201466_CR215
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2013.02.017
– volume: 161
  start-page: 1116
  year: 2004
  ident: BFmp201466_CR64
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.161.6.1116
– volume: 29
  start-page: 662
  year: 2006
  ident: BFmp201466_CR166
  publication-title: Neuroimage
  doi: 10.1016/j.neuroimage.2005.07.038
– volume: 112
  start-page: 192
  year: 2009
  ident: BFmp201466_CR82
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2009.04.026
– volume: 20
  start-page: 285
  year: 1990
  ident: BFmp201466_CR207
  publication-title: Psychol Med
  doi: 10.1017/S0033291700017608
– volume: 149
  start-page: 112
  year: 2013
  ident: BFmp201466_CR143
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2013.06.040
– volume: 16
  start-page: 471
  year: 2013
  ident: BFmp201466_CR67
  publication-title: Int J Neuropsychopharmacol
  doi: 10.1017/S1461145712000314
– volume: 107
  start-page: 1225
  year: 2008
  ident: BFmp201466_CR117
  publication-title: J Neurochem
  doi: 10.1111/j.1471-4159.2008.05675.x
– volume: 13
  start-page: 1102
  year: 2007
  ident: BFmp201466_CR127
  publication-title: Nat Med
  doi: 10.1038/nm1632
– volume: 38
  start-page: 9
  year: 2012
  ident: BFmp201466_CR61
  publication-title: Schizophr Bull
  doi: 10.1093/schbul/sbr133
– volume: 148
  start-page: 165
  year: 2006
  ident: BFmp201466_CR190
  publication-title: Psychiatry Res
  doi: 10.1016/j.pscychresns.2006.05.009
– volume: 115
  start-page: 88
  year: 2009
  ident: BFmp201466_CR65
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2009.08.012
– volume: 263
  start-page: 367
  year: 2013
  ident: BFmp201466_CR124
  publication-title: Eur Arch Psychiatry Clin Neurosci
  doi: 10.1007/s00406-013-0399-y
– volume: 67
  start-page: 133
  year: 2010
  ident: BFmp201466_CR145
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archgenpsychiatry.2009.193
– volume: 290
  start-page: 2155
  year: 2000
  ident: BFmp201466_CR90
  publication-title: Science
  doi: 10.1126/science.290.5499.2155
– volume: 67
  start-page: 1247
  year: 2013
  ident: BFmp201466_CR142
  publication-title: Int J Clin Pract
  doi: 10.1111/ijcp.12269
– volume: 63
  start-page: 9
  year: 2008
  ident: BFmp201466_CR126
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2007.04.038
– volume: 14
  start-page: 776
  year: 2013
  ident: BFmp201466_CR139
  publication-title: Psychol Sport Exerc
  doi: 10.1016/j.psychsport.2013.04.005
– volume: 168
  start-page: 921
  year: 2011
  ident: BFmp201466_CR57
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.2011.11010052
– volume: 23
  start-page: 126
  year: 2013
  ident: BFmp201466_CR156
  publication-title: Eur Neuropsychopharmacol
  doi: 10.1016/j.euroneuro.2012.04.015
– volume: 34
  start-page: 354
  year: 2008
  ident: BFmp201466_CR6
  publication-title: Schizophr Bull
  doi: 10.1093/schbul/sbm168
– volume: 10
  start-page: 13
  year: 2012
  ident: BFmp201466_CR15
  publication-title: Clin Psychopharmacol Neurosci
  doi: 10.9758/cpn.2012.10.1.13
– volume: 204
  start-page: 322
  year: 2009
  ident: BFmp201466_CR110
  publication-title: Behav Brain Res
  doi: 10.1016/j.bbr.2008.12.022
– volume: 98
  start-page: 1200
  year: 2006
  ident: BFmp201466_CR53
  publication-title: J Neurochem
  doi: 10.1111/j.1471-4159.2006.03964.x
– volume: 148
  start-page: 163
  year: 2013
  ident: BFmp201466_CR136
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2013.05.027
– volume: 42
  start-page: 157
  year: 2004
  ident: BFmp201466_CR224
  publication-title: Folia Neuropathol
– volume: 78
  start-page: 27
  year: 2005
  ident: BFmp201466_CR59
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2005.05.010
– volume: 506
  start-page: 179
  year: 2014
  ident: BFmp201466_CR49
  publication-title: Nature
  doi: 10.1038/nature12929
– volume: 65
  start-page: 39
  year: 2003
  ident: BFmp201466_CR173
  publication-title: Schizophr Res
  doi: 10.1016/S0920-9964(03)00006-9
– volume: 70
  start-page: 663
  year: 2011
  ident: BFmp201466_CR102
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2011.04.013
– volume: 24
  start-page: 101
  year: 2014
  ident: BFmp201466_CR32
  publication-title: J Neuroimaging
  doi: 10.1111/j.1552-6569.2012.00779.x
– volume: 77
  start-page: 736
  year: 2013
  ident: BFmp201466_CR50
  publication-title: Neuron
  doi: 10.1016/j.neuron.2012.12.032
– volume: 148
  start-page: 59
  year: 2013
  ident: BFmp201466_CR68
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2013.05.024
– volume: 99
  start-page: 218
  year: 2008
  ident: BFmp201466_CR195
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2007.11.028
– volume: 67
  start-page: 146
  year: 2010
  ident: BFmp201466_CR135
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archgenpsychiatry.2009.192
– volume: 70
  start-page: 1057
  year: 2013
  ident: BFmp201466_CR198
  publication-title: JAMA Psychiatry
  doi: 10.1001/jamapsychiatry.2013.289
– volume: 66
  start-page: 562
  year: 2009
  ident: BFmp201466_CR33
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2009.03.013
– volume: 15
  start-page: 4
  year: 2010
  ident: BFmp201466_CR119
  publication-title: CNS Spectr
  doi: 10.1017/S1092852900027681
– volume: 33
  start-page: 465
  year: 2008
  ident: BFmp201466_CR125
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1301444
– volume: 60
  start-page: 621
  year: 2006
  ident: BFmp201466_CR168
  publication-title: Biological Psychiatry
  doi: 10.1016/j.biopsych.2006.01.010
– volume: 25
  start-page: 159
  year: 2006
  ident: BFmp201466_CR180
  publication-title: Rev Esp Med Nucl
  doi: 10.1157/13088411
– volume: 69
  start-page: 562
  year: 2012
  ident: BFmp201466_CR25
  publication-title: Arch Gen Psychiatry
– volume: 68
  start-page: 199
  year: 2013
  ident: BFmp201466_CR39
  publication-title: Adv Pharmacol
  doi: 10.1016/B978-0-12-411512-5.00010-5
– volume: 122
  start-page: 43
  year: 2010
  ident: BFmp201466_CR177
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2010.03.043
– volume: 70
  start-page: 664
  year: 2013
  ident: BFmp201466_CR109
  publication-title: JAMA Psychiatry
  doi: 10.1001/jamapsychiatry.2013.210
– volume: 17
  start-page: 211
  year: 2011
  ident: BFmp201466_CR138
  publication-title: Eur Addict Res
  doi: 10.1159/000327682
– volume: 42
  start-page: 151
  year: 2008
  ident: BFmp201466_CR220
  publication-title: J Psychiatr Res
  doi: 10.1016/j.jpsychires.2006.10.013
– volume: 39
  start-page: 120
  year: 2013
  ident: BFmp201466_CR80
  publication-title: Schizophr Bull
  doi: 10.1093/schbul/sbr069
– volume: 28
  start-page: 13957
  year: 2008
  ident: BFmp201466_CR106
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.4457-08.2008
– volume: 7
  start-page: 31
  year: 2013
  ident: BFmp201466_CR46
  publication-title: Front Cell Neurosci
  doi: 10.3389/fncel.2013.00031
– volume: 19
  start-page: 1217
  year: 2010
  ident: BFmp201466_CR130
  publication-title: Expert Opin Investig Drugs
  doi: 10.1517/13543784.2010.513382
– volume: 55
  start-page: 126
  year: 2004
  ident: BFmp201466_CR7
  publication-title: Biol Psychiatry
  doi: 10.1016/S0006-3223(03)00728-5
– volume: 174
  start-page: 403
  year: 2006
  ident: BFmp201466_CR146
  publication-title: Exp Brain Res
  doi: 10.1007/s00221-006-0472-0
– volume: 66
  start-page: 606
  year: 2009
  ident: BFmp201466_CR169
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archgenpsychiatry.2009.43
– volume: 21
  start-page: 861
  year: 2011
  ident: BFmp201466_CR167
  publication-title: Eur Neuropsychopharmacol
  doi: 10.1016/j.euroneuro.2011.03.004
– volume: 168
  start-page: 1311
  year: 2011
  ident: BFmp201466_CR38
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.2011.11010160
– volume: 26
  start-page: 1273
  year: 2012
  ident: BFmp201466_CR208
  publication-title: Brain Behav Immun
  doi: 10.1016/j.bbi.2012.08.005
– volume: 346
  start-page: 1130
  year: 1995
  ident: BFmp201466_CR171
  publication-title: Lancet
  doi: 10.1016/S0140-6736(95)91801-9
– volume: 39
  start-page: 121
  year: 2014
  ident: BFmp201466_CR141
  publication-title: Brain Behav Immun
  doi: 10.1016/j.bbi.2014.01.003
– volume: 161
  start-page: 1496
  year: 2004
  ident: BFmp201466_CR191
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.161.8.1496
– volume: 11
  start-page: 476
  year: 2008
  ident: BFmp201466_CR104
  publication-title: Nat Neurosci
  doi: 10.1038/nn2071
– volume: 21
  start-page: 1043
  year: 1986
  ident: BFmp201466_CR216
  publication-title: Biol Psychiatry
  doi: 10.1016/0006-3223(86)90285-4
– volume: 93
  start-page: 261
  year: 2007
  ident: BFmp201466_CR152
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2007.03.022
– volume: 37
  start-page: 85
  year: 2014
  ident: BFmp201466_CR41
  publication-title: Trends Neurosci
  doi: 10.1016/j.tins.2013.11.003
– volume: 36
  start-page: 857
  year: 2013
  ident: BFmp201466_CR149
  publication-title: Sleep
  doi: 10.5665/sleep.2712
– volume: 68
  start-page: 128
  year: 2011
  ident: BFmp201466_CR11
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archgenpsychiatry.2010.199
– volume: 109
  start-page: 16720
  year: 2012
  ident: BFmp201466_CR43
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1208494109
– volume: 102
  start-page: 163
  year: 2008
  ident: BFmp201466_CR204
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2008.03.012
– volume: 36
  start-page: 1781
  year: 2011
  ident: BFmp201466_CR66
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2011.65
– ident: BFmp201466_CR129
– volume: 39
  start-page: 1096
  year: 2013
  ident: BFmp201466_CR62
  publication-title: Schizophr Bull
  doi: 10.1093/schbul/sbs092
– volume: 468
  start-page: 187
  year: 2010
  ident: BFmp201466_CR131
  publication-title: Nature
  doi: 10.1038/nature09552
– volume: 68
  start-page: 489
  year: 2011
  ident: BFmp201466_CR31
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archgenpsychiatry.2011.42
– volume: 59
  start-page: 663
  year: 2002
  ident: BFmp201466_CR45
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.59.7.663
– volume: 108
  start-page: 78
  year: 2009
  ident: BFmp201466_CR182
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2008.11.006
– volume: 137
  start-page: 172
  year: 2014
  ident: BFmp201466_CR14
  publication-title: Brain
  doi: 10.1093/brain/awt310
– volume: 22
  start-page: 1459
  year: 1987
  ident: BFmp201466_CR217
  publication-title: Biol Psychiatry
  doi: 10.1016/0006-3223(87)90104-1
– volume: 129
  start-page: 169
  year: 2011
  ident: BFmp201466_CR183
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2011.03.012
– volume: 26
  start-page: 8
  year: 2012
  ident: BFmp201466_CR18
  publication-title: J Psychopharmacol
  doi: 10.1177/0269881111408964
– volume: 70
  start-page: 271
  year: 2013
  ident: BFmp201466_CR94
  publication-title: JAMA Psychiatry
  doi: 10.1001/2013.jamapsychiatry.86
– volume: 94
  start-page: 328
  year: 2007
  ident: BFmp201466_CR77
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2007.05.008
– volume: 101
  start-page: 133
  year: 2008
  ident: BFmp201466_CR186
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2007.11.010
– volume: 10
  start-page: 131
  year: 2006
  ident: BFmp201466_CR107
  publication-title: Neurotox Res
  doi: 10.1007/BF03033242
– volume: 104
  start-page: 1361
  year: 1997
  ident: BFmp201466_CR212
  publication-title: J Neural Transm
  doi: 10.1007/BF01294737
– volume: 69
  start-page: 97
  year: 2011
  ident: BFmp201466_CR196
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2010.08.033
– volume: 38
  start-page: 72
  year: 2014
  ident: BFmp201466_CR103
  publication-title: Neurosci Biobehav Rev
  doi: 10.1016/j.neubiorev.2013.11.006
– volume: 36
  start-page: 2325
  year: 2012
  ident: BFmp201466_CR16
  publication-title: Neurosci Biobehav Rev
  doi: 10.1016/j.neubiorev.2012.07.012
– volume: 61
  start-page: 397
  year: 2012
  ident: BFmp201466_CR5
  publication-title: Neuroimage
  doi: 10.1016/j.neuroimage.2011.11.080
– volume: 37
  start-page: 189
  year: 2011
  ident: BFmp201466_CR70
  publication-title: Schizophr Bull
  doi: 10.1093/schbul/sbp074
– volume: 66
  start-page: 89
  year: 2004
  ident: BFmp201466_CR123
  publication-title: Schizophr Res
  doi: 10.1016/S0920-9964(03)00129-4
– volume: 23
  start-page: 675
  year: 2013
  ident: BFmp201466_CR144
  publication-title: Eur Neuropsychopharmacol
  doi: 10.1016/j.euroneuro.2012.08.008
– volume: 22
  start-page: 3708
  year: 2002
  ident: BFmp201466_CR163
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.22-09-03708.2002
– volume: 20
  start-page: 1004
  year: 2012
  ident: BFmp201466_CR86
  publication-title: Eur J Hum Genet
  doi: 10.1038/ejhg.2012.38
– volume: 169
  start-page: 1203
  year: 2012
  ident: BFmp201466_CR113
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.2012.12010144
– volume: 92
  start-page: 108
  year: 2007
  ident: BFmp201466_CR115
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2007.01.019
– volume: 61
  start-page: 1218
  year: 2007
  ident: BFmp201466_CR74
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2006.05.037
– volume: 84
  start-page: 100
  year: 2006
  ident: BFmp201466_CR34
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2006.02.005
– ident: BFmp201466_CR181
  doi: 10.1007/s00213-006-0570-5
– volume: 191
  start-page: 325
  year: 2007
  ident: BFmp201466_CR203
  publication-title: Br J Psychiatry
  doi: 10.1192/bjp.bp.106.033670
– volume: 25
  start-page: 859
  year: 2011
  ident: BFmp201466_CR122
  publication-title: CNS Drugs
  doi: 10.2165/11586650-000000000-00000
– volume: 66
  start-page: 533
  year: 2009
  ident: BFmp201466_CR69
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2009.05.006
– volume: 173
  start-page: 183
  year: 2009
  ident: BFmp201466_CR187
  publication-title: Psychiatry Res
  doi: 10.1016/j.pscychresns.2008.11.001
– volume: 3
  start-page: 320
  year: 2012
  ident: BFmp201466_CR92
  publication-title: Transl Neurosci
  doi: 10.2478/s13380-012-0045-6
– volume: 460
  start-page: 744
  year: 2009
  ident: BFmp201466_CR87
  publication-title: Nature
  doi: 10.1038/nature08186
– volume: 43
  start-page: 2301
  year: 2013
  ident: BFmp201466_CR22
  publication-title: Psychol Med
  doi: 10.1017/S0033291713000238
– volume: 126
  start-page: 414
  year: 1975
  ident: BFmp201466_CR211
  publication-title: Br J Psychiatry
  doi: 10.1192/bjp.126.5.414
– volume: 93
  start-page: 103
  year: 2000
  ident: BFmp201466_CR209
  publication-title: Psychiatry Res
  doi: 10.1016/S0165-1781(00)00104-9
– volume: 18
  start-page: 466
  year: 2012
  ident: BFmp201466_CR112
  publication-title: Curr Pharm Des
  doi: 10.2174/138161212799316244
– volume: 50
  start-page: 1801
  year: 2009
  ident: BFmp201466_CR97
  publication-title: J Nucl Med
  doi: 10.2967/jnumed.109.066647
– volume: 885
  start-page: 117
  year: 2000
  ident: BFmp201466_CR223
  publication-title: Brain Res
  doi: 10.1016/S0006-8993(00)02984-X
– volume: 2
  start-page: e190
  year: 2012
  ident: BFmp201466_CR17
  publication-title: Transl Psychiatry
  doi: 10.1038/tp.2012.116
– volume: 50
  start-page: 468
  year: 2009
  ident: BFmp201466_CR99
  publication-title: J Nucl Med
  doi: 10.2967/jnumed.108.058669
– volume: 28
  start-page: 401
  year: 2002
  ident: BFmp201466_CR36
  publication-title: Schizophr Bull
  doi: 10.1093/oxfordjournals.schbul.a006949
– volume: 35
  start-page: 549
  year: 2009
  ident: BFmp201466_CR40
  publication-title: Schizophr Bull
  doi: 10.1093/schbul/sbp006
– volume: 13
  start-page: 943
  year: 2010
  ident: BFmp201466_CR98
  publication-title: Int J Neuropsychopharmacol
  doi: 10.1017/S1461145710000313
– volume: 41
  start-page: 625
  year: 2007
  ident: BFmp201466_CR200
  publication-title: J Psychiatr Res
  doi: 10.1016/j.jpsychires.2006.07.002
– volume: 262
  start-page: 183
  year: 2012
  ident: BFmp201466_CR188
  publication-title: Eur Arch Psychiatry Clin Neurosci
  doi: 10.1007/s00406-011-0269-4
– volume: 69
  start-page: 19
  year: 2011
  ident: BFmp201466_CR79
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2010.08.024
– volume: 40
  start-page: 181
  year: 2014
  ident: BFmp201466_CR132
  publication-title: Schizophr Bull
  doi: 10.1093/schbul/sbt139
– volume: 91
  start-page: 617
  year: 1999
  ident: BFmp201466_CR4
  publication-title: J Neurosurg
  doi: 10.3171/jns.1999.91.4.0617
– volume: 1239
  start-page: 235
  year: 2008
  ident: BFmp201466_CR101
  publication-title: Brain Res
  doi: 10.1016/j.brainres.2008.08.023
– volume: 35
  start-page: 41
  year: 1999
  ident: BFmp201466_CR172
  publication-title: Schizophr Res
  doi: 10.1016/S0920-9964(98)00113-3
– volume: 12
  start-page: 824
  year: 2006
  ident: BFmp201466_CR48
  publication-title: Nat Med
  doi: 10.1038/nm1418
– volume: 38
  start-page: 1040
  year: 2012
  ident: BFmp201466_CR155
  publication-title: Schizophr Bull.
  doi: 10.1093/schbul/sbr017
– volume: 71
  start-page: 265
  year: 2014
  ident: BFmp201466_CR81
  publication-title: JAMA Psychiatry
  doi: 10.1001/jamapsychiatry.2013.3939
– volume: 34
  start-page: 354
  year: 2008
  ident: BFmp201466_CR20
  publication-title: Schizophr Bull.
  doi: 10.1093/schbul/sbm168
– volume: 31
  start-page: 11088
  year: 2011
  ident: BFmp201466_CR58
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.1234-11.2011
– volume: 168
  start-page: 1303
  year: 2011
  ident: BFmp201466_CR93
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.2011.11030516
– volume: 68
  start-page: 881
  year: 2011
  ident: BFmp201466_CR194
  publication-title: Arch. Gen. Psychiatry
  doi: 10.1001/archgenpsychiatry.2011.46
– volume: 124
  start-page: 1309
  year: 2013
  ident: BFmp201466_CR147
  publication-title: Clin Neurophysiol
  doi: 10.1016/j.clinph.2013.01.014
– volume: 18
  start-page: 133
  year: 2013
  ident: BFmp201466_CR114
  publication-title: Mol Psychiatry
  doi: 10.1038/mp.2012.199
– volume: 52
  start-page: 424
  year: 2013
  ident: BFmp201466_CR26
  publication-title: Br J Clin Psychol
  doi: 10.1111/bjc.12027
– volume: 66
  start-page: 13
  year: 2009
  ident: BFmp201466_CR37
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archgenpsychiatry.2008.514
SSID ssj0014765
Score 2.540982
SecondaryResourceType review_article
Snippet It is evident that once psychosis is present in patients with schizophrenia, the underlying biological process of the illness has already been ongoing for many...
SourceID pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 84
SubjectTerms 631/378/2649
631/378/340
692/699/476/1799
692/700/565
Age of Onset
Anniversaries
Antipsychotic Agents - therapeutic use
Antipsychotics
Behavioral Sciences
Biological Psychology
Brain - pathology
Care and treatment
Cognition Disorders - etiology
Dopamine
Expert Review
Humans
Longitudinal studies
Medical imaging
Medicine
Medicine & Public Health
Neurobiology
Neuroimaging
Neurophysiology
Neurosciences
Pharmacotherapy
Physiological aspects
Psychiatric research
Psychiatry
Psychosis
Psychotropic drugs
Receptors, N-Methyl-D-Aspartate - metabolism
Schizophrenia
Schizophrenia - complications
Schizophrenia - genetics
Schizophrenia - pathology
Schizophrenia - therapy
SummonAdditionalLinks – databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3dS-QwEB88xcMX8eNO6xcVBfGh57ZJ2u6jLIoI3tMJvoV8lVvQ7uKuD_73zqRp2a4--FbIJB2STDLDTH4_gHNnmCOMjyTVlGYslUi0I0pA7SqR6cyqkt4OP_zN7x75_ZN4CjA5s1BW2UBa-mO6rQ67eiFsyZT_yfMfsEaQ7bSbR_moyxjwwtNGpkxQZrPkLRQpKxf69i6f5SN44Q5aro9cSpL6u-d2CzaD0xhfN2puw4qrd2C9oZF834GfDyFBvutZ42OPURnQlWJV27irJo8nVVyN0eFL3HQ8m1gXzxaL7n7B4-3Nv9FdEhgSEpNzMU-GNsXZpEydy1KlhBowy4012UBjmFXhba2Ys5xpU5mBIm4XzTItiBJTmaLi7Des1pPa7UNsBK8sH1ZlpoecD0uMmyxGzpYZNNJswCO4bKdOmgAfTiwWz9KnsVkpX6aSplnmeQRnney0Ac34UuqCVkCSJeFIRoUHAagPYVLJa054c3hGiAiOepJoAabf3K6hDBY4kylBAxYFBskRnHbN1JOqymo3efMymXfI0gj2miXv9CVoN3SmcfCitxk6AcLl7rfU4_8en5sTJ32J_z1vt82CWp-m4eB7YoewgV-iKRg_gtX565s7Rn9ork-8IXwAerMG7w
  priority: 102
  providerName: Springer Nature
Title The neurobiology and treatment of first-episode schizophrenia
URI https://link.springer.com/article/10.1038/mp.2014.66
https://www.ncbi.nlm.nih.gov/pubmed/25048005
https://www.proquest.com/docview/1650977978
https://www.proquest.com/docview/1652439761
https://pubmed.ncbi.nlm.nih.gov/PMC4320288
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS9xAEB-sUuhL8bNNtZJSQfqQesnuJrmnoocihYqIwr0t-xU8qMm1dz743zuz2cS7s_Qx7CRZZmd3Z3Zmfz-AI2eYI4yPJNWUZiyVSLQjSkDtKpHpzKqS7g7_usov7_jPsRiHA7dZKKvs1kS_UNvG0Bn5SUpQb0WBQc-P6Z-EWKMouxooNN7ABkGXUUlXMe4DrpQXnkoyZYKynSXv4ElZefJAWJUp_-7REV82pNVleWFfWq2ZXEmc-v3oYhPeB0cyPm1HfgvWXL0Nb1tqyacdTx8fe7DKALMUq9rGfVl53FRxNUHPL3HTyayxLp4tVt_twt3F-e3oMglUCYnJuZgnQ5uiWill57JUKaEGzHJjTTbQGG9VuG0r5ixn2lRmoIjkRbNMC-LGVKaoONuD9bqp3UeIjeCV5cOqzPSQ82GJAZTFENoyg7M1G_AIvnX6kibgiBOdxW_p89mslA9TSbqVeR7B11522qJn_FPqmNQuaUrhl4wKNwOwPwROJU85Ac_hYiEiOFiSxKlglpu7gZNhKs7ki-FE8KVvpjepvKx2zaOXybxnlkbwoR3nvr-E8YZeNX68WLKAXoAAupdb6sm9B-rmRE5f4n-POltZ6NYrNXz6f-_34R0KirZi_ADW538f3Wd0iOb60Fv9IWycnV9d3-DTKB89A2xLC48
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxNBDLZKKgQXxJuFAosoQhyWZueR3RwQKtAqpW2EUCv1Np3Xikh0N5BUqH-K34g9-2gSELeexzuxPPbYjj2fATa95Z4wPpLUUJkx1zIxnkYCGl9IZpjTOb0dPhwPRsfi84k8WYPf7VsYaqts78RwUbvK0n_kWylBvWUZJj3vpz8SmhpF1dV2hEatFvv-4hembLN3e5_wfF8xtrtz9HGUNFMFEjsQcp4MXYocUHXLs1RrqfvcCess6xtMTQr0cJp7J7ixhe1rmodiODOSxkhqmxWC477XYF1wTGV6sP5hZ_zla1e3EFkYXplySfXVXLSAqDzfOiN0zFS8DXiMly5w1REseMLVLs2VUm3wgLu34VYTusbbta7dgTVf3oXr9TDLi3thYH0c4DEbYKdYly7uGtnjqoiLCcaaiZ9OZpXz8Wyx3-8-HF-JGB9Ar6xK_whiK0XhxLDImRkKMcwxZXOYtDtu8X5gfRHBm1ZeyjbI5TRA47sKFXSeq7OpItmqwSCClx3ttMbr-CfVaxK7IiPGnaxu3iIgPwSHpbYFQd3h9SQj2FiiROOzy8vtwanG-GfqUlUjeNEt05fU0Fb66jzQsBALphE8rM-545dQ5TCOx82zJQ3oCAgSfHmlnHwL0OCCMwwY8Xc3W11ZYOsvMTz-P_fP4cbo6PBAHeyN95_ATfxI1v3qG9Cb_zz3TzEcm5tnjQ3EcHrVZvcHcQBHgQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VIlAvqLwNLRhRhDiYxPuInUNVVZSopVBxoFJu231ZRGrtQFKh_jV-HTPrR5OAuPW8481od56Z2W8AdrzlnjA-ktRQmTHXMjGeRgIaX0hmmNM5vR3-cjI4PBWfxnK8Br_btzDUVtnaxGCoXWXpP_JeSlBvWYZJT69o2iK-Hoz2pj8SmiBFldZ2nEYtIsf-6hemb7PdowO86zeMjT5--3CYNBMGEjsQcp4MXYrcUKXLs1RrqfvcCess6xtMUwr0dpp7J7ixhe1rmo1iODOSRkpqmxWC47634HbGZUo6lo27ZC8VWRhjmXJJldZctNCoPO9dEE5mKt4HZMZrZ7jqEhZ84mq_5krRNvjC0Sbca4LYeL-Wuvuw5ssHcKcea3n1MIyujwNQZgPxFOvSxV1Le1wVcTHBqDPx08mscj6eLXb-PYLTGznEx7BeVqV_CrGVonBiWOTMDIUY5pi8OUzfHbdoKVhfRPCuPS9lGwxzGqVxrkItnefqYqrobNVgEMHrjnZaI3f8k-otHbsidcadrG5eJSA_BIyl9gWB3qGhkhFsLVGiGtrl5fbiVGMGZupaaCN41S3Tl9TaVvrqMtCwEBWmETyp77njl_DlMKLHzbMlCegICBx8eaWcfA8g4YIzDB3xd3daWVlg669jePZ_7l_CXVQ29fno5Pg5bOA3sm5c34L1-c9Lv41x2dy8CAoQw9lNa9wfF99KUQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+neurobiology+and+treatment+of+first-episode+schizophrenia&rft.jtitle=Molecular+psychiatry&rft.au=Kahn%2C+R+S&rft.au=Sommer%2C+I+E&rft.date=2015-02-01&rft.pub=Nature+Publishing+Group&rft.issn=1359-4184&rft.eissn=1476-5578&rft.volume=20&rft.issue=1&rft.spage=84&rft_id=info:doi/10.1038%2Fmp.2014.66&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=3578564111
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1359-4184&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1359-4184&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1359-4184&client=summon